WO2004000150A1 - Method and apparatus for photothermal treatment of tissue at depth - Google Patents

Method and apparatus for photothermal treatment of tissue at depth Download PDF

Info

Publication number
WO2004000150A1
WO2004000150A1 PCT/US2003/019474 US0319474W WO2004000150A1 WO 2004000150 A1 WO2004000150 A1 WO 2004000150A1 US 0319474 W US0319474 W US 0319474W WO 2004000150 A1 WO2004000150 A1 WO 2004000150A1
Authority
WO
WIPO (PCT)
Prior art keywords
tissue
selected region
radiation
region
depth
Prior art date
Application number
PCT/US2003/019474
Other languages
French (fr)
Inventor
Gregory B. Altshuler
Andrei V. Erofeev
Henry M. Zenzie
R. Rox Anderson
Dieter Manstein
James Burke, Iii
Andrew Radl
Michael Z. Smirnov
Original Assignee
Palomar Medical Technologies, Inc.
The General Hospital Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2004516013A priority Critical patent/JP2006500972A/en
Priority to PCT/US2003/019474 priority patent/WO2004000150A1/en
Priority to EP03737199A priority patent/EP1523283A1/en
Priority to BR0311901-7A priority patent/BR0311901A/en
Priority to US10/465,137 priority patent/US7351252B2/en
Priority to CA2487987A priority patent/CA2487987C/en
Application filed by Palomar Medical Technologies, Inc., The General Hospital Corporation filed Critical Palomar Medical Technologies, Inc.
Priority to AU2003238302A priority patent/AU2003238302B2/en
Priority to CNB038140454A priority patent/CN100482182C/en
Publication of WO2004000150A1 publication Critical patent/WO2004000150A1/en
Priority to IL197542A priority patent/IL197542A/en
Priority to IL165418A priority patent/IL165418A/en
Priority to HK06100339.4A priority patent/HK1080341A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/203Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452Skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452Skin
    • A61B2018/00458Deeper parts of the skin, e.g. treatment of vascular disorders or port wine stains
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452Skin
    • A61B2018/00476Hair follicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N2007/0004Applications of ultrasound therapy
    • A61N2007/0008Destruction of fat cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy

Definitions

  • This invention relates to methods and apparatus for the photothermal treatment of tissue and, more particularly, to methods and apparatus for photothermal treatment of at least a selected region of tissue located starting at a depth at about the boundary zone of dermal and subdermal tissue and extending therebelow.
  • heated pads or plates or various forms of electromagnetic radiation including microwave radiation, electricity, infrared radiation and ultrasound have previously been used for heating subdermal muscles, ligaments, bones and the like to, for example, increase blood flow, to otherwise promote the healing of various injuries and other damage, and for various therapeutic purposes, such as frostbite or hyperthermia treatment, treatment of poor blood circulation, physical therapy, stimulation of collagen, cellulite treatment, adrenergic stimulation, wound healing, psoriasis treatment, body reshaping, non-invasive wrinkle removal, etc.
  • the heating of tissues has also been utilized as a potential treatment for removing cancers or other undesired growths, infections and the like. Heating may be applied over a small localized area, over a larger area, for example to the hands or feet, or over larger regions of tissue, including the entire body.
  • optical radiation While optical and near infrared (MR) radiation ( collectively referred to hereinafter as “optical radiation” is generally both less expensive and, being non-mutagenic, safer than microwaves radiation, the use of optical radiation has heretofore not been considered suitable for most applications involving heating of tissue at depth, the term "tissue at depth” as used herein meaning tissue at the border zone of the dermis and hypodermis, some of which tissue may be in the lower dermis, mostly at a depth deeper than 1 mm, and tissue below this border zone to a depth of up to about 50 mm The reason why this radiation has not been considered suitable is because such radiation is both highly scattered and highly absorbed in surface layers of tissue, precluding significant portions of such radiation from reaching the tissue regions at depth to cause heating thereof.
  • the present invention generally relates to methods and apparatus for photothermal treatment, both therapeutic and cosmetic, of tissue located at depth in a patient's body, as this term has previously been defined.
  • Optical radiation utilized in practicing the invention is at a wavelength or wavelength band which is neither highly scattered in the patient's skin nor highly absorbed by water in tissue so that the maximum quantity of such radiation can reach the treatment region at depth.
  • the wavelength utilized typically is between about 600 nm and about 1850 nm, more preferably between about 800 nm and about 1350nm, and most preferably between about 1050 nm and about 1250 nm.
  • Other potential ranges for certain depths of tissue are set forth in Table 1.
  • tissue to be treated may be a chromophore at the wavelength(s) utilized within the above bands, this is not a limitation on the invention, and absorption by water, and to a lesser extent fat or lipid, in the region is generally sufficient to achieve the desired heating. In some applications, absorption at certain wavelengths can be increased by delivering a suitable chromophore to the treatment region.
  • the optical radiation source utilized may be a monochromatic source, such as a laser or light emitting diode (LED), or may be a wide spectrum source such as a halogen lamp or arc lamp.
  • the source may also be a pulsed source or a continuous wave (CW) source. Natural light sources such the sun can also be used to practice this invention. Where the source is a pulsed source, the source typically remains over a treatment region for the duration of each pulse, or a train of pulses may be applied. Where the source is a (CW) source, it is typically moved over the surface of the patients skin at a selected rate, the rate of movement determining the dwell time over a given treatment region.
  • CW continuous wave
  • the invention also requires that cooling be applied to the patient's skin surface concurrently with the application of optical radiation thereto. While the radiation reaches the tissue at depth to be treated quickly to begin the heating thereof, cooling propagates as a cold wave protecting tissue above the treatment region and moving the depth of maximum heating further into the skin. Ideally the cooling wave propagates to a depth just above the treatment region, but does not extend to the treatment region at least until sufficient energy has been delivered to the treatment region to effect the desired treatment Cooling may also be applied to the patient's skin prior to the application of radiation thereto to more effectively protect tissue above the treatment region and to more rapidly result in maximum heat being at or near the desired depth. This may also permit higher energy and shorter duration for the radiation source. The head used to apply the radiation may also be used to apply cooling.
  • the radiation is applied at low power for an extended time, the time varying with the depth of treatment and with the treatment being performed.
  • the time may vary from approximately 2 seconds to approximately 2 hours for depths of approximately 1 mm to 50 mm respectively.
  • the power density may vary from approximately 0.2 to 50 W/cm2, more preferably from approximately 0.5 to 20 W/cm2, and most preferably from 0.5 to 10 W/cm2 or 0.5 to 5 W/cm2.
  • Fig. 1 is a schematic diagram of one embodiment of the invention, as applied to a tissue sample
  • Fig. 2 is a schematic diagram of another embodiment of the invention, showing an internal design configuration
  • Fig. 3 is a schematic diagram of another embodiment of the invention, showing another internal design configuration
  • Fig. 4 is a schematic diagram of another embodiment of the invention, showing another internal design configuration
  • Fig. 5 is a schematic diagram of another embodiment of the invention, showing another; internal design configuration
  • Fig. 6 is a schematic diagram of another embodiment of the invention, showing another internal design configuration
  • Fig. 7 is a schematic diagram illustrating a plurality of devices of the invention being used in conjunction with each other;
  • Fig. 8 is a schematic diagram of another embodiment of the invention, showing yet another internal design configuration;
  • Fig. 9 is a schematic diagram of another embodiment of the invention having a different configuration
  • Fig. 10 is a schematic drawing of a model of tissue, used in certain calculations
  • Fig. 11 is a plot of the temperature produced by an embodiment of the invention in a tissue sample versus tissue depth
  • Fig. 12 is a plot of a temperature relaxation profile produced by an embodiment of the invention in a tissue; and Fig. 13 is a plot of depth of heating vs. treatment time as determined using Equation 12.
  • varios diseases particularly, cellulite and subcutaneous fat treatment
  • physical therapy including relief of pain and stiffness for muscles and joints
  • treatment of spinal cord problems and treatment of cumulative trauma disorders (CTD's) such as carpel tunnel syndrome (CTS), tendonitis and bursitis, fibromyalgia, lymphedema and cancer therapy.
  • CTD's cumulative trauma disorders
  • CTS carpel tunnel syndrome
  • tendonitis and bursitis fibromyalgia
  • lymphedema lymphedema
  • hyperthermia resulting from utilizing the teachings of this invention may be utilized to treat various skin cancers including, but not limited to, basel cell carcinoma, squamous cell carcinoma, lymphoma and possibly treatment (palliative) of melanoma.
  • Hyperthermia may also enhance the efficacy of radiation , for example x-ray, therapy, chemotherapy, therapy with immunmodulators such as ALDARA or PDT therapy. Such combination therapy may for example reduce required treatment time.
  • the tissue to be treated may be a collagen-rich tissue. Collagen-rich tissues that may be treated include superficial cortical bone, synovium joint capsules, tendon sheaths, menisci, myofascial interfaces, periosteum, fibrotic muscle, or major nerve trunks.
  • the device may also be used for reshaping procedures such as non-invasive wrinkle removal through stimulation of collagen production in a subsurface region of tissue.
  • Heating of the subsurface region of tissue to a temperature of between 37.5 and 45 °C may stimulate generation of new collagen and/or elastin.
  • expression of HSP70 Heat Shock Protein
  • Other proteins, cytokins and/or growth factors may also be stimulated or released in response to heating.
  • Significant new collagen deposition, formation or rearrangement may be possible, which may improve skin appearance or texture, allowing wrinkles, fine lines, scars, stretch marks or other indicators to be removed.
  • Hypothermia resulting from utilizing the teachings of this invention may also be utilized for hair growth management, and for treatment of psoriasis, scars, rosacea and various conditions of toe and finger nails.
  • hair growth management which includes temporary and permanent hair removal and control of hair growth
  • a dermal or subdermal temperature rise of a few degrees, for example to 42-45° C can produce an anagen effluvium. This could be particularly useful for hair grow management on hairs containing little or no melanin, for example gray, white or blond hairs.
  • the efficacy of such treatment may be enhanced by using wavelengths absorbed by melanin or by performing the treatment in conjunction with other hair removal techniques.
  • Hypothermia may also be used to treat psoriasis, including psoriasis plaques and nail psoriasis.
  • the teachings of this invention may thus be used to treat psoriasis, either alone or conjunction drug treatment, light treatment, for example with an excimer laser, flashlamp, uv or pulse dye laser, or other existing treatment.
  • Scars having different crosslinking and different denaturation thresholds then normal tissue, may be treated by hypothermia to, for example, reduce turnover, turnover being significantly enhanced for scar tissue.
  • a special handpiece with an aperture adjustable to the shape of the scar may be desirable for treating scars.
  • hypothermia induced in accordance with the teachings of the invention may also be used to kill demodex mites resident in follicles which cause rosacea.
  • hypothermia induced by this invention may be used to enhance or control growth rate of toe or finger nails or to otherwise treat conditions of these nails, for example nail fungus and dystrophic nails.
  • the nail (matrix) is relatively accessible to light treatment.
  • the nails can be cooled by emergence in a water bath and exposed to the light.
  • the mechanism for enhanced nail growth may be enhanced metabolism, blood supply (vasodialation by heat and light) or biostimulation.
  • thermal energy to tissue may also be used, for example, in physical therapy treatments, such as to enhance or accelerate wound healing or relieve pain.
  • Beneficial effects may include a decrease in joint stiffness, an increase in joint extensibility of collagenous structures such as tendons and scar tissue, pain relief, blood-flow changes, or a decrease in muscle spasm and increase in muscle tone.
  • large protein molecules may have high absorption coefficients, and the heating of protein-rich collagenous tissues may contribute to healing.
  • a wide variety of conditions may be treated using this invention, for example, but not limited to, strained tendons, tenosynovitis, torn ligaments, tendonitis, bursitis, torn joint capsules, or torn muscles.
  • tissue processes may be activated or deactivated within the tissue during heating.
  • heating of the tissue may be used to enhance or modify the activity of a pharmaceutical or another bioactive substance or to facilitate the delivery thereof through the skin.
  • Mechanical or electrical stimulation such as massage, may be used in conjunction with heating to achieve benefits greater then can be achieved by either alone.
  • Pressure may also be applied to the skin surface above the treatment region to facilitate the treatment.
  • the damage temperature is the temperature by which cells, collagen, or other tissue components may be irreversibly damaged.
  • the damage temperature may be useful in certain therapeutic situations, for example, to damage unwanted cells or other structures, such as collagen, malignant or benign tumors, hair bulb, deep pigmented lesions or fat. Further, by heating tissue to a temperature above the body temperature (typically 37°C), but below the damage temperature, it may be possible to change the dynamics of various biological processes, such as metabolism.
  • tissue is a tumor
  • heat in accordance with the teachings of this invention to kill the tumor, or at least a portion thereof, such as a necrotic center.
  • tissue is an artificially created tissue, such as a tissue-engineered scaffold
  • preferential heating of the center of the artificial tissue may be used, for example, to stimulate cell division within the tissue, to promote cell division or cell growth within the artificial tissue structure.
  • the present invention may be used for non-invasive or nondestructive reduction of localized fat deposits.
  • the invention may be used to heat fat or adipose cells past their damage temperature, causing cell damage and/or necrosis.
  • the treated cells may undergo apoptosis, resulting in cell death.
  • the dead cells may then be removed or resorbed into the body, for example, by the body's phagocytic or lymphatic systems.
  • Fat reduction may also be achieved by heating fat or adipose cells to an elevated temperature, but below the damage temperature.
  • the fat cells may be heated to a temperature of between about 41°C and about 45°C.
  • applying heat to subcutaneous fat may activate lipases or metabolize lipids contained within the adipose tissue found within the subcutaneous fat layer, or blood flow may increase to the heated area.
  • lipases or the process of breaking down fat in the body, may be regulated by enzymes sensitive to temperature, such as HSL ("hormone-sensitive lipase").
  • HSL hormone-sensitive lipase
  • elevating the temperature of the adipose cells may increase the lipolysis rate, and thus contribute to a reduction in subdermal fat in the area being treated. This temperature can be below the temperature for vascular/lymph damage so damaged fatty cells and fatty acids can be easily removed from the treatment region.
  • application of the present invention may be used in combination with other fat-reduction techniques, such as medication, exercise, or adrenergic stimulation Heating of subcutaneous fat may also result in increased dermal thickness.
  • fatty tissue may be replaced by fibrous and dermal tissue, this resulting in improved skin appearance..
  • Thermal activation of lymph systems in subcutaneous fat can also be used to treat cellulite by removing proteins from extra cell spaces.
  • fat and/or cellulite reduction may be achieved utilizing the teachings of this invention by providing an elevated (but below damage threshold ⁇ 43-48°C) temperature in the targeted region at depth.
  • the mild hyperthermia initiates biological response through one or several of the following pathways:
  • Fig. 1 shows an apparatus 100 for one embodiment of the invention.
  • optical energy 30 from a suitable energy source 1 passes through optical (for example, focusing) device 2, filter 3, cooling mechanism 4 and contact plate 8, before reaching tissue 31.
  • a suitable optical impedance matching lotion or other suitable substance would typically be applied between plate 8 and tissue 31 to provide enhanced optical and thermal contact.
  • Tissue 31, as shown in Fig. 1, is divided into an upper region 5, which, for applications where radiation is applied to the skin surface, would be the epidermis and dermis, and a lower region 6 which would be a subdermal region in the previous example.
  • Energy 30 possibly in conjunction with one or a combination of focusing from optical device 2, and wavelength selection from filter 3, and with cooling from mechanism 4, results in maximum heating occurring at a selected depth in tissue 31, which depth is, as previously indicated, at or near the junction of regions 5 and 6 or in lower region 6 for this invention.
  • certain of these components such as, for example, filter 3 where a monochromatic source is utilized or optics 2, may not necessarily be present.
  • energy source 1, optical device 2 and/or filter 3 may also require a cooling mechanism.
  • This cooling mechanism may or may not be the same as or connected to cooling mechanism 4 that cools tissue 31 through contact plate 8, as indicated by arrows 32 in Fig. 1.
  • cooling mechanism 7, shown separately from cooling mechanism 4 is used to cool filter 3.
  • Energy source 1 may be any suitable optical energy source able to produce optical energy 30 at a wavelength that produces heating within tissue 31 at the depth of a desired treatment region.
  • the exact energy source, and the exact energy chosen may be a function of the tissue 31 to be heated, the depth within the tissue at which treatment is desired and of the absorption of that energy in the desired area to be treated.
  • energy source 1 may be a radiant lamp, a halogen lamp, an incandescent lamp, a arc lamp, a fluorescent lamp, a light emitting diode, a laser (including diode and fiber lasers), the sun or other suitable optical energy source.
  • Energy source 1 may produce electromagnetic radiation, such as near infrared or visible light radiation over a broad spectrum, over a limited spectrum or at a single wavelength, such as would be produced by a light emitting diode or a laser.
  • a narrow spectral source may be preferable, as the wavelength(s) produced by the energy source may be targeted towards a specific tissue type or may be adapted for reaching a selected depth.
  • a wide spectral source may be preferable, for example, in systems where the wavelength(s) to be applied to the tissue may change, for example, by applying different filters, depending on the application.
  • the optical radiation produced by energy source 1 should be radiation with a wavelength which is minimally scattered and absorbed, the available wavelengths decreasing with increasing depth as generally indicated in Table 1.
  • Certain wavelengths may be preferentially absorbed by the tissue to be treated. As one example, if the tissue to be treated includes subcutaneous fat, certain wavelengths may be absorbed more effectively by the fat or adipose cells than by the surrounding tissues.
  • optical radiation having wavelengths around 925 nm, 1206 nm, 1730 nm and 2300 nm may be desirable (see for example copending application serial #09/277307, which is incorporated herein by reference, for suitable ranges); however, only the lower three of these ranges would typically provide sufficient penetration for use in practicing this invention.
  • electromagnetic radiation of these wavelengths the coefficient of absorption by this radiation in the lipids, and in particular the triglycerides located within the adipose tissue may be greater than that of the absorption coefficient of these wavelengths in water.
  • these wavelengths when applied to a tissue sample will preferentially be absorbed by the fat tissue, thus resulting in the preferential heating of this tissue.
  • the selective heating of the fatty tissue can be enhanced by the lower heat capacity of fatty tissue vs. aqueous tissue.
  • the decreased blood perfusion of the subcutaneous fat vs. the dermis can be used to enhance selective heating of the fatty tissue.
  • Compression sufficient to reduce blood flow within the target area can minimize unwanted heat convection, and therefore heat leakage, from the target area.
  • the compression to the subdermal target area can be made selective by forming a skin fold and applying skin pressure sidewise. This results in compression of the subcutaneous fat and of skin outside the field of optical exposure.
  • the skin on top of the skin fold, which skin is exposed to the optical radiation, is not compressed, and therefore the blood flow therein is not appreciably reduced so long as the length of the skin fold does not exceed a critical length. Blood flow within the part of the dermis exposed to optical radiation can help to remove unwanted excessive heat in this skin component.
  • optical device 2 is a focusing device, it may be any suitable device able to focus at least a portion of energy 30 arriving from energy source 1 at tissue 31, and in particular at a selected depth in tissue 31.
  • device 2 may include mirrors, prisms, reflectors, lenses such as Fresnel lenses, collimating lenses or focusing lenses, diffraction gratings, or other optical device.
  • Filter 3 may be any suitable filter able to select, or at least partially select, certain wavelengths or wavelength bands from energy source 1. In certain types of filters, a specific set of wavelengths may be blocked by the filter.
  • filter 3 may include elements designed to absorb, reflect or alter certain wavelengths of electromagnetic radiation.
  • filter 3 may be used to remove certain types of wavelengths that are absorbed by surrounding tissues.
  • dermis and epidermis tissues are primarily composed of water, as is much of the rest of the human body.
  • a water-based filter may be used to decrease the amount of radiation absorbed in tissue above the treatment region and converted into heat.
  • filter 3 may be combined with other elements of the device, for example, cooling system 4 or cooling mechanism 7.
  • water may both attenuate energy 30 arising from energy source 1, as well as cool the contact plate, and tissue in contact with the contact plate, or various other components of the device. More than one filter or filter type may also be present.
  • Fig. 1 shows a cooling mechanism 4 adjacent to the surface of tissue 31.
  • Cooling mechanism 4 may be any suitable cooling mechanism able to reduce the temperature of tissue 31.
  • Heat energy 32 may be drawn from tissue 31 across contact plate 8 into cooling mechanism 4.
  • cooling system 4 may be air or other suitable gas that is blown over contact plate 8, cooling water, or a cooling oil or other fluid. Mixtures of these substances, such as an oil and water mixture, may also be envisioned.
  • Cooling mechanism 4 may have any suitable configuration, for example, a flat plate, a series of conducting pipes, a sheathing blanket, or a series of channels for the passage of air, or other gases, or liquid across plate 8.
  • cooling system 4 may be a water-cooled contact plate.
  • cooling mechanism 4 may be a series of channels carrying a coolant fluid or a refrigerant fluid (for example, a cryogen), which channels are in contact with tissue 31 or with plate 8.
  • cooling system 4 may comprise a water or refrigerant fluid (for example RI 34A) spray, a cool air spray or air flow across the surface of tissue 31.
  • cooling may be accomplished through chemical reactions (for example, endothermic reactions), or through electronic cooling, such as Peltier cooling.
  • cooling mechanism 4 may have more than one type of coolant, or cooling mechanism 4 and/or contact plate 8 may be absent, for example, in embodiments where the tissue is cooled passively or directly, for example, through a cryogenic or other suitable spray.
  • Cooling mechanism 4 may also be embedded in cooling mechanism 4, for example, to monitor the temperature, or determine the degree of cooling required by tissue 31, and be manually or electronically controlled.
  • cooling mechanism 4 may be used to maintain the surface temperature of tissue 31 at its normal temperature, which may be, for example, 37 or 32 °C, depending on the type of tissue being heated.
  • cooling mechanism 4 may be used to decrease the temperature of the surface of tissue 31 to a temperature below the normal temperature of that type of tissue.
  • cooling mechanism 4 may be able to decrease the surface temperature of tissue 31 to, for example, a range between 25 °C and -5 °C.
  • cooling mechanism 4 may be constructed out of materials able to transmit at least a portion of energy 30, for example, air, water or other gases or fluids, glass, or a clear plastic.
  • cooling mechanism 4 may be formed out of a series of discrete channels, and energy 30 may pass between these channels.
  • energy 30 may not be directed through cooling mechanism 4.
  • energy source 19 and cooling system 18 may be positioned on opposite sides of chamber 17.
  • Contact plate 8 may be made out of a suitable heat transfer material, and also, where the plate contacts tissue 31, of a material having a good optical match with the tissue.
  • contact plate 8 may have a high degree of thermal conductivity, for example, to allow cooling of the surface of the tissue by cooling mechanism 4. In other embodiments, contact plate 8 may be an integral part of cooling mechanism 4, or be absent. Contact plate 8 may be made out of a deformable or viscoelastic material in some embodiments of the invention, for example, a gel such as a hydrogel. In other embodiments, contact plate 8 may be made of a solid material, such as a glass, a crystal such as sapphire, or a plastic. In some embodiments of the invention, such as shown in Fig. 1 , energy 30 from energy source 1 may pass through contact plate 8.
  • contact plate 8 may be constructed out of materials able to transmit at least a portion of energy 30, for example glass, sapphire, or a clear plastic, or contact plate 8 may be constructed in such a way as to allow at least a portion of energy 30 to pass through contact plate 8, for example, via a series of holes within contact plate 8.
  • cooling mechanism 7 may be a function of the components used in the construction of the apparatus. Cooling mechanism 7 and cooling mechanism 4, in Fig. 1, are illustrated as separate systems. However, in other embodiments, cooling mechanism 7 and cooling mechanism 4 may be part of the same system, or one or both may be absent. Cooling mechanism 7 may be any suitable cooling mechanism known in the art, such as air, water, or an oil. Mixtures of these substances, such as an oil and water mixture, may also be envisioned. Cooling of the components may be accomplished through convective or conductive cooling.
  • One or more of energy source 1, optical device 2, filter 3, cooling mechanism 4, or cooling mechanism 7 may be electronically controlled.
  • sensors embedded in cooling mechanism 4 or contact plate 8 may determine the amount of energy reaching tissue 31, and may direct energy source 1 to produce more or less energy or may direct cooling mechanism 4 to increase or decrease cooling, depending on the application.
  • Other sensors and the like may be embedded in any of the components illustrated herein.
  • the controls may be, for example, electronically preprogrammed, or manually operable.
  • the present invention is not limited to treating a specific region or area of tissue.
  • the invention may be constructed in such a way as to treat an entire person.
  • chamber 17 contains cooling mechanism 18 and energy source 19.
  • Cooling mechanism 18 may be cooled in the same ways described above for cooling mechanisms 4 and 7.
  • Energy source 19 may contain, for example, a series of lamps or other energy sources, optionally surrounded by filters 40. In this embodiment, filters 40 are built into the side of chamber 17.
  • Fig. 9 shows another design, where chamber 17 has a cooling mechanism 18, but does not contain an energy source.
  • energy 42 from the sun 41 or another energy source is directed to chamber 17, for example, directly, by means of reflectors 20, or by means of a lens such as Fresnel lens 19.
  • the patient may be cooled within the chamber by air flow or other suitable cooling mechanism 18.
  • a lamp 9 for example an incandescent lamp, is used as the energy source.
  • Lamp 9 is surrounded by a specially coated reflector 10 to maximize light delivery efficiency to the treatment region of tissue 31 .
  • a fluid 13 may pass between contact plate 8 and filter 3.
  • Contact plate 8, cooled by fluid 13, may cool the surface of the tissue to which it is applied.
  • lamp 9 has been replaced by a monochromatic light emitting element 1 1 and lens 12, element 11 being, for example a laser diode, other suitable laser or a light emitting diode.
  • element 11 being, for example a laser diode, other suitable laser or a light emitting diode.
  • contact plate 8 and filter 3 are cooled by fluid 13 flowing therebetween; these two components may also be cooled by flow of cold liquid gas, for example R134A, from a pressurized can.
  • this embodiment illustrates how a monocromatic element 1 1 may be used as the energy source.
  • FIG. 4 A different type of cooling mechanism is illustrated in Fig. 4.
  • energy arising from energy source 1 is reflected using reflector 10 through filter 3, a transparent isolating material 16, and contact plate 8.
  • Two fluids are used to cool the filter and the contact plate.
  • Upper fluid 14 flows between filter 3 and isolating material 16, while lower fluid 15 passes between isolating material 16 and contact plate 8.
  • Fluids 14 and 15, in this embodiment may not be the same fluid; however, in other embodiments, the two fluids may be the same fluid, or have a common reservoir.
  • Contact plate 8, in this embodiment may be made out of, for example, a transparent or a semi-transparent material, such as a glass, plastic or sapphire.
  • contact plate 8 may be formed out of an opaque material, but have openings to allow energy to pass through contact plate 8.
  • FIG. 5 A similar embodiment of the invention is shown in Fig. 5, where the energy source 1 has been replaced by an element that produces discrete wavelengths, such as a light emitting diode or a laser diode 1 1.
  • Optional lens 12 has also been added to the system as illustrated in Fig. 5.
  • contact plate 8 may be absent.
  • fluid 13 for example a liquid, gas such as air or a spray
  • Legs 42 connected to the device may be constructed in such a manner as to correctly position filter 3 over the surface of the tissue.
  • Legs 42 may be any component able to maintain a proper distance between the surface of tissue 31 and device 100.
  • legs 42 may be constructed out of a flexible or a semi-solid substance that, for example, may conform to the surface of tissue 31, such as a gel.
  • legs 42 may be constructed out of a solid substance, such as rubber or plastic.
  • Legs 42 may have any arrangement underneath the device that allows for the proper positioning of the device relative to the tissue.
  • legs 42 may be arranged in a triangular or a square pattern.
  • legs 42 may be a ring or a series of bars that surrounds the area being treated or legs 42 may be absent. More than one device 100 of this invention may be used simultaneously.
  • a series of devices 100 have been arranged into a semicircular pattern. These devices may be linked together to treat large areas of a subject's body. Additionally, the devices may be interconnected in such a way as to provide flexibility, so that, for example, the apparatus may conform to the contours of the body. For example, the device may be worn as a belt, a leg wrap, an arm wrap, or wrapped around the torso. Devices 100 may also be mounted to a chair, bed or other suitable surface for the treatment of a patient's back, thighs and/or buttocks. Alternatively, devices 100 may be used to create an array of small island areas within a larger area (see for example copending application serial 10/033,302 which is incorporated herein by reference).
  • This may, for example, be a safer alternative to large area heating, particularly for extended treatment regimens.
  • By optimizing the spacing between treated areas for example, through the addition of "masks" in filter 3 between energy source 1 and tissue 31 that block portions of the energy arising from energy source 1, and/or through the use of multiple separate devices 100 as is shown in Fig. 7, treatment of the subdermal tissue may be maximized, while causing a minimal amount of patient discomfort, and/or allowing faster recovery time.
  • optical source 1 is a continuous wave (CW) or other long duration source
  • device 100 for various of the embodiments may be slid or scanned over the surface of the patient's skin to overlie successive treatment regions, the dwell time, and thus the treatmentduration, for each such region being a function of the rate at which the device is moved
  • the device may also include a cooling mechanism ahead of the portion of the device under source 1 to precool skin above the treatment region (see for example issued U.S. Patents Nos. 6,273,884 and 6,511,475, which are incorporated herein by reference).
  • any of the embodiments can include a contact sensor to assure good optical and thermal coupling, and systems operating in the sliding mode may also include one or more motion sensors to control radiation delivery, cooling and other functions dependent on scanning speed, to enhance system safety and for other reasons.
  • device 100 may also include a massager, vibrator or other mechanical stimulation device or a DC or other suitable electrical stimulation source. It has been found that such mechanical or electrical stimulation is more effective for hot tissue. Similarly, the effect of deep heating may be enhanced by massage or other stimulation because both heat and cold generally penetrates better in compressed skin and subdermal tissue. Thus, the combination of deep heating and mechanical or electrical stimulation may provide significantly better results then either one alone. Heating may also be enhanced by supplementing the optical heating with, for example electro-stimulation by AC/DC, or additional heating by RF, etc. Tensioning or pressure applied to the skin overlying the treatment region may also enhance treatment effect.
  • the teachings of this invention may also be utilized for hair removal treatments by targeting the hair bulb, which is generally located in the subcutaneous layer 6.
  • the treatment would be done at low power sufficient to raise the temperature of the fat surrounding the hair bulb, and thus the hair bulb, to roughly 45°C and should be performed for a relatively long time period, for example, 15 minutes.
  • the hair bulb also contains high proliferation water cells which react strongly with the applied radiation to increase bulb temperature, leading to the destruction thereof.
  • This example illustrates theoretical calculations corresponding to one embodiment of the invention as applied to human skin.
  • the one-dimensional light transport problem in the diffusion approximation for the two-layered tissue model of Fig. 10 can be solved assuming both the tissue irradiance and the light flux to be the continuous functions of coordinate z at the dermis and fat interface.
  • the resulting expression for the tissue irradiance, ⁇ obtained may be written in the following general form:
  • indices 1 and 2 stand for dermis and subcutaneous fat, respectively.
  • ⁇ v ' ⁇ a ' ⁇ lr and + . are the diffusion and extinction coefficients for light in the corresponding
  • ⁇ -T ⁇ z,t a k ⁇ T T ⁇ z,t)+ Q k (z,t), ot dz (2) yielding the following steady-state equation:
  • the temperature distribution was:
  • Tmax Th - Ts is maximum temperature rise in the tissue at the depth zmax.
  • Equation (10) was solved numerically. To get an approximate analytic expression, the inequality ⁇ t » /rwas used, which is typically valid within the therapeutic window. Then, dropping the exponential terms with ⁇ t , and solving the simplified equation with respect to z max yielded the following
  • / is the depth into dermis and z 2 is depth into subcutaneous fat
  • z ⁇ + z 2 z is depth of treatment
  • the treatment time must be longer than t m ⁇ n .
  • Fig. 1 1 shows a typical temperature distribution in the body.
  • Fig. 13 and Table 2 show minimum treatment time as a function of depth of treatment z.
  • Equations (10), (1 1), and (12) describe a set of heating and cooling parameters that allow control of both the value and location of the internal temperature maximum.
  • Fig. 1 1 shows a graph generated using these equations that shows that a broad spectral source, having a proper set of filters, combined with surface cooling, allows the temperature within the adipose layer of tissue to be elevated to a maximum, while maintaining acceptable temperatures surrounding tissue and in particular, in tissue above the treatment region through which the radiation passes.
  • this example illustrates theoretical calculations corresponding to one embodiment of the invention.
  • the following prophetic example illustrates treatment parameters for different body layers that may be used in one embodiment of the invention, as applied to human skin.
  • treatment parameters for different layers of the body that may be used in one embodiment of the invention can be determined. These calculations are summarized in Table 1.
  • the body layers model includes the reticular dermis, dermis subcutaneous fat junction, and subcutaneous fat layer.
  • the treatment parameters include a surface cooling mechanism able to maintain a surface cooling temperature of between 0 °C and 32 °C; a broad-spectrum lamp, where the color temperature of the lamp is between 300 K and 3000 K, with filtering of more than 50% of the light having wavelengths of less than 800 nm and greater that 1800 nm, preferably 900 to 1400 nm, and most preferably 1 100 to 1250 nm .
  • the power may vary from approximately 0.2 to 50 W/cm2, and more preferably from approximately 0.5 to 20 W/cm2, with a treatment time of between 2 sec for a 1mm depth and 7300 sec for a 50 mm depth
  • treatment power and duration increase.
  • this prophetic example illustrates exemplary treatment parameters that may be used to heat different layers of the body, in one embodiment of the invention.
  • Example 3 In this example, a device 100 of this invention substantially as shown in Fig.2 was used to heat subcutaneous fat in the stomach region of a volunteer. Light from a halogen lamp 9 was filtered with a combination of a short cut or high pass filter 8 with an 800 nm cut-off and a 3 mm thick water layer 41. The temperature of water 41 was 12°C, while the temperature of a sapphire plate 8 and of the skin interface was 18°C. Power density was 4W/cm2 and the treatment time was 300 sec.
  • thermocouples were immediately implanted 1 mm and 8 mm below the skin surface under the heated region to determine the final, steady-state temperatures and to monitor the temperature relaxation profiles in the dermis and fat layer respectively. Temperature data recorded by the two thermocouples are shown in Fig. 12. The initial temperature of the subcutaneous fat layer at a depth of 8 mm was found to be approximately 45 °C, while the temperature of the dermis, 1 mm below the surface of the skin, was found to be about 40 °C and the temperature at the epidermis was 24°C. Over the course of the next several minutes, the temperatures of the dermis and the subcutaneous fat layer decreased towards basal levels of 37 °C for the subcutaneous fat layer and approximately 32 °C for the dermis. '
  • the same device 100 was used to perform the same test on a 25 mm bulk of pig skin and subcutaneous fat which was placed on a thermally stable plate with a temperature of 37°C.
  • the power density for this test was 10 W/cm2 and cooling water having a temperature of 4°C was used.
  • peak temperature of 53°C was found at a depth 14 mm into the fat.
  • the temperature at the epidermis at this time was 38°C.
  • this exposure setting induced reduction of subcutaneous fat without evidence for epidermal damage.
  • a partial replacement of fatty tissue by connective collagen tissue was observed.
  • a reduction of hair growth was also observed several weeks after this and similar exposure settings, even if a lower temperature rise was obtained and only a single treatment was performed.

Abstract

The present invention provides method and apparatus for treating tissue in a region at depth by applying optical radiation thereto of a wavelength able to reach the depth of the region and of a selected relatively low power for a duration sufficient for the radiation to effect the desired treatment while concurrently cooling tissue above the selected region to protect such tissue. Treatment may be enhanced by applying mechanical, acoustic or electrical stimulation to the region.

Description

METHOD AND APPARATUS FOR PHOTOTHERMAL TREATMENT OF TISSUE AT DEPTH
CROSS-REFERENCE TO RELATED APPLICATION
This invention claims the benefit of co-pending U.S. Provisional Patent Application Serial No. 60/389,871, filed June 19, 2002, entitled "Method and Apparatus for Subdermal Heating," by G. Altshuler, et al., incorporated herein by reference in its entirety.
BACKGROUND
Field of the Invention
This invention relates to methods and apparatus for the photothermal treatment of tissue and, more particularly, to methods and apparatus for photothermal treatment of at least a selected region of tissue located starting at a depth at about the boundary zone of dermal and subdermal tissue and extending therebelow.
Description of the Related Art
The benefits of being able to raise and/or lower the temperature in a selected region of tissue for various therapeutic and cosmetic purposes has been known for some time. For instance, heated pads or plates or various forms of electromagnetic radiation, including microwave radiation, electricity, infrared radiation and ultrasound have previously been used for heating subdermal muscles, ligaments, bones and the like to, for example, increase blood flow, to otherwise promote the healing of various injuries and other damage, and for various therapeutic purposes, such as frostbite or hyperthermia treatment, treatment of poor blood circulation, physical therapy, stimulation of collagen, cellulite treatment, adrenergic stimulation, wound healing, psoriasis treatment, body reshaping, non-invasive wrinkle removal, etc. The heating of tissues has also been utilized as a potential treatment for removing cancers or other undesired growths, infections and the like. Heating may be applied over a small localized area, over a larger area, for example to the hands or feet, or over larger regions of tissue, including the entire body.
Since most of the techniques described above involve applying energy to tissue at depth through the patient's skin surface, peak temperature generally occurs at or near the patient's skin surface and decrease, sometimes significantly, with depth. Further, while microwaves or ultrasonic and other acoustic radiation have been used in the past for certain heating treatments at depth, as disclosed in, for example, U.S. Patent No. 5,871,524 to Knowlton, U.S. Patent No. 5,769,879 to Richards, et al., U.S. Patent No. 5,507,790 to Weiss, or U.S. Patent No. 5, 143,063 to Fellner, since such radiation, particularly microwaves, are potentially mutagenic and can otherwise result in cell or systemic damage and, particularly for acoustic sources, are relatively expensive, and may not be practical for large-area treatment, these techniques have had limited use for the heating of tissues.
While optical and near infrared (MR) radiation ( collectively referred to hereinafter as "optical radiation" is generally both less expensive and, being non-mutagenic, safer than microwaves radiation, the use of optical radiation has heretofore not been considered suitable for most applications involving heating of tissue at depth, the term "tissue at depth" as used herein meaning tissue at the border zone of the dermis and hypodermis, some of which tissue may be in the lower dermis, mostly at a depth deeper than 1 mm, and tissue below this border zone to a depth of up to about 50 mm The reason why this radiation has not been considered suitable is because such radiation is both highly scattered and highly absorbed in surface layers of tissue, precluding significant portions of such radiation from reaching the tissue regions at depth to cause heating thereof. In view of the energy losses due to scattering and absorption, substantial optical ( including NIR) energy must be applied in order for enough such energy to reach a region of tissues at depth to have a desired effect. However, such high energy can cause damage to the surface layers of tissue, making it difficult to achieve desired photothermal treatments in tissue regions at depth. For these reasons, optical radiation has heretofore had at most limited value for therapeutic and cosmetic treatments on tissue at depth. Further, while heating of tissue at depth alone is useful for many treatments, there are treatments, for example to relieve pain and stiffness in muscles or joints, where heating in conjunction with massage or other mechanical stimulation, ultrasound or other acoustic stimulation or electrical stimulation of the tissue may also be useful. Thus, a need exists for improved method and apparatus for photothermal treatment of tissue regions at depth, and in particular for treatment of subdermal regions of tissue, and for method and apparatus for combining heating with stimulation in such regions for various treatments.
SUMMARY OF THE INVENTION
The present invention generally relates to methods and apparatus for photothermal treatment, both therapeutic and cosmetic, of tissue located at depth in a patient's body, as this term has previously been defined. Optical radiation utilized in practicing the invention is at a wavelength or wavelength band which is neither highly scattered in the patient's skin nor highly absorbed by water in tissue so that the maximum quantity of such radiation can reach the treatment region at depth. The wavelength utilized typically is between about 600 nm and about 1850 nm, more preferably between about 800 nm and about 1350nm, and most preferably between about 1050 nm and about 1250 nm. Other potential ranges for certain depths of tissue are set forth in Table 1. The longer the wavelength, the lower the scattering; however, outside of the indicated bands, water absorption is so high that little radiation can reach tissue at depth. While the tissue to be treated may be a chromophore at the wavelength(s) utilized within the above bands, this is not a limitation on the invention, and absorption by water, and to a lesser extent fat or lipid, in the region is generally sufficient to achieve the desired heating. In some applications, absorption at certain wavelengths can be increased by delivering a suitable chromophore to the treatment region. The optical radiation source utilized may be a monochromatic source, such as a laser or light emitting diode (LED), or may be a wide spectrum source such as a halogen lamp or arc lamp. Where a wide spectrum source is used, filtering or shifting of wavelengths outside the above bands may be performed. The source may also be a pulsed source or a continuous wave (CW) source. Natural light sources such the sun can also be used to practice this invention. Where the source is a pulsed source, the source typically remains over a treatment region for the duration of each pulse, or a train of pulses may be applied. Where the source is a (CW) source, it is typically moved over the surface of the patients skin at a selected rate, the rate of movement determining the dwell time over a given treatment region.
The invention also requires that cooling be applied to the patient's skin surface concurrently with the application of optical radiation thereto. While the radiation reaches the tissue at depth to be treated quickly to begin the heating thereof, cooling propagates as a cold wave protecting tissue above the treatment region and moving the depth of maximum heating further into the skin. Ideally the cooling wave propagates to a depth just above the treatment region, but does not extend to the treatment region at least until sufficient energy has been delivered to the treatment region to effect the desired treatment Cooling may also be applied to the patient's skin prior to the application of radiation thereto to more effectively protect tissue above the treatment region and to more rapidly result in maximum heat being at or near the desired depth. This may also permit higher energy and shorter duration for the radiation source. The head used to apply the radiation may also be used to apply cooling. Another feature of the invention is that the radiation is applied at low power for an extended time, the time varying with the depth of treatment and with the treatment being performed. For example, the time may vary from approximately 2 seconds to approximately 2 hours for depths of approximately 1 mm to 50 mm respectively. Depending on depth, the treatment being performed and other factors, the power density may vary from approximately 0.2 to 50 W/cm2, more preferably from approximately 0.5 to 20 W/cm2, and most preferably from 0.5 to 10 W/cm2 or 0.5 to 5 W/cm2.
Other advantages, novel features, and objects of the invention will become apparent from the following detailed description of the invention when considered in conjunction with the accompanying drawings, which are schematic and which are not intended to be drawn to scale. In the figures, each identical, or substantially similar component that is illustrated in various figures is represented by a single numeral or notation. For purposes of clarity, not every component is labeled in every figure, nor is every component of each embodiment of the invention shown where illustration is not necessary to allow those of ordinary skill in the art to understand the invention.
BRIEF DESCRIPTION OF THE DRAWINGS Non-limiting embodiments of the present invention will be described by way of example with reference to the accompanying drawings in which:
Fig. 1 is a schematic diagram of one embodiment of the invention, as applied to a tissue sample;
Fig. 2 is a schematic diagram of another embodiment of the invention, showing an internal design configuration;
Fig. 3 is a schematic diagram of another embodiment of the invention, showing another internal design configuration; Fig. 4 is a schematic diagram of another embodiment of the invention, showing another internal design configuration;
Fig. 5 is a schematic diagram of another embodiment of the invention, showing another; internal design configuration
Fig. 6 is a schematic diagram of another embodiment of the invention, showing another internal design configuration;
Fig. 7 is a schematic diagram illustrating a plurality of devices of the invention being used in conjunction with each other; Fig. 8 is a schematic diagram of another embodiment of the invention, showing yet another internal design configuration;
Fig. 9 is a schematic diagram of another embodiment of the invention having a different configuration; Fig. 10 is a schematic drawing of a model of tissue, used in certain calculations;
Fig. 11 is a plot of the temperature produced by an embodiment of the invention in a tissue sample versus tissue depth;
Fig. 12 is a plot of a temperature relaxation profile produced by an embodiment of the invention in a tissue; and Fig. 13 is a plot of depth of heating vs. treatment time as determined using Equation 12.
DETAILED DESCRIPTION
Applications in which the invention may be useful include the treatment of varios diseases, particularly, cellulite and subcutaneous fat treatment, physical therapy, muscle and skeletal treatments, including relief of pain and stiffness for muscles and joints, and treatment of spinal cord problems, and treatment of cumulative trauma disorders (CTD's) such as carpel tunnel syndrome (CTS), tendonitis and bursitis, fibromyalgia, lymphedema and cancer therapy. More specifically with respect to cancer therapy, hyperthermia resulting from utilizing the teachings of this invention may be utilized to treat various skin cancers including, but not limited to, basel cell carcinoma, squamous cell carcinoma, lymphoma and possibly treatment (palliative) of melanoma. Hyperthermia may also enhance the efficacy of radiation , for example x-ray, therapy, chemotherapy, therapy with immunmodulators such as ALDARA or PDT therapy. Such combination therapy may for example reduce required treatment time. The tissue to be treated may be a collagen-rich tissue. Collagen-rich tissues that may be treated include superficial cortical bone, synovium joint capsules, tendon sheaths, menisci, myofascial interfaces, periosteum, fibrotic muscle, or major nerve trunks. The device may also be used for reshaping procedures such as non-invasive wrinkle removal through stimulation of collagen production in a subsurface region of tissue. Heating of the subsurface region of tissue to a temperature of between 37.5 and 45 °C may stimulate generation of new collagen and/or elastin. For example, expression of HSP70 ("Heat Shock Protein") may be stimulated when the tissue is heated to between 41 and 42 °C for between 20 and 30 minutes. Other proteins, cytokins and/or growth factors may also be stimulated or released in response to heating. Significant new collagen deposition, formation or rearrangement may be possible, which may improve skin appearance or texture, allowing wrinkles, fine lines, scars, stretch marks or other indicators to be removed. In general, there exists a relation between the temperature reached and the time of application that is necessary to stimulate new collagen deposition and prevent irreversible damage. Additionally, multiple treatments may be used in some treatment modalities.
Hypothermia resulting from utilizing the teachings of this invention may also be utilized for hair growth management, and for treatment of psoriasis, scars, rosacea and various conditions of toe and finger nails. For hair growth management, which includes temporary and permanent hair removal and control of hair growth, a dermal or subdermal temperature rise of a few degrees, for example to 42-45° C can produce an anagen effluvium. This could be particularly useful for hair grow management on hairs containing little or no melanin, for example gray, white or blond hairs. The efficacy of such treatment may be enhanced by using wavelengths absorbed by melanin or by performing the treatment in conjunction with other hair removal techniques. Hypothermia may also be used to treat psoriasis, including psoriasis plaques and nail psoriasis. The teachings of this invention may thus be used to treat psoriasis, either alone or conjunction drug treatment, light treatment, for example with an excimer laser, flashlamp, uv or pulse dye laser, or other existing treatment. Scars, having different crosslinking and different denaturation thresholds then normal tissue, may be treated by hypothermia to, for example, reduce turnover, turnover being significantly enhanced for scar tissue. A special handpiece with an aperture adjustable to the shape of the scar may be desirable for treating scars. Hypothermia induced in accordance with the teachings of the invention may also be used to kill demodex mites resident in follicles which cause rosacea. Finally, hypothermia induced by this invention may be used to enhance or control growth rate of toe or finger nails or to otherwise treat conditions of these nails, for example nail fungus and dystrophic nails. The nail (matrix) is relatively accessible to light treatment. The nails can be cooled by emergence in a water bath and exposed to the light. The mechanism for enhanced nail growth may be enhanced metabolism, blood supply (vasodialation by heat and light) or biostimulation.
The application of thermal energy to tissue may also be used, for example, in physical therapy treatments, such as to enhance or accelerate wound healing or relieve pain. Beneficial effects may include a decrease in joint stiffness, an increase in joint extensibility of collagenous structures such as tendons and scar tissue, pain relief, blood-flow changes, or a decrease in muscle spasm and increase in muscle tone. As another example, large protein molecules may have high absorption coefficients, and the heating of protein-rich collagenous tissues may contribute to healing. A wide variety of conditions may be treated using this invention, for example, but not limited to, strained tendons, tenosynovitis, torn ligaments, tendonitis, bursitis, torn joint capsules, or torn muscles. As yet another example, other processes may be activated or deactivated within the tissue during heating. For example, heating of the tissue may be used to enhance or modify the activity of a pharmaceutical or another bioactive substance or to facilitate the delivery thereof through the skin. Mechanical or electrical stimulation, such as massage, may be used in conjunction with heating to achieve benefits greater then can be achieved by either alone. Pressure may also be applied to the skin surface above the treatment region to facilitate the treatment.
In another example, when tissue is heated to greater then the damage temperature of the tissue, irreversible changes to the tissue may occur, up to and including cell death, apoptosis or the like. The damage temperature is the temperature by which cells, collagen, or other tissue components may be irreversibly damaged. The damage temperature may be useful in certain therapeutic situations, for example, to damage unwanted cells or other structures, such as collagen, malignant or benign tumors, hair bulb, deep pigmented lesions or fat. Further, by heating tissue to a temperature above the body temperature (typically 37°C), but below the damage temperature, it may be possible to change the dynamics of various biological processes, such as metabolism. Where the tissue is a tumor, it may be desired to use heat in accordance with the teachings of this invention to kill the tumor, or at least a portion thereof, such as a necrotic center. Where the tissue is an artificially created tissue, such as a tissue-engineered scaffold, preferential heating of the center of the artificial tissue may be used, for example, to stimulate cell division within the tissue, to promote cell division or cell growth within the artificial tissue structure.
In certain embodiments, the present invention may be used for non-invasive or nondestructive reduction of localized fat deposits. For example, the invention may be used to heat fat or adipose cells past their damage temperature, causing cell damage and/or necrosis. Alternatively, the treated cells may undergo apoptosis, resulting in cell death. The dead cells may then be removed or resorbed into the body, for example, by the body's phagocytic or lymphatic systems. Fat reduction may also be achieved by heating fat or adipose cells to an elevated temperature, but below the damage temperature. For example, the fat cells may be heated to a temperature of between about 41°C and about 45°C. Under these conditions, applying heat to subcutaneous fat may activate lipases or metabolize lipids contained within the adipose tissue found within the subcutaneous fat layer, or blood flow may increase to the heated area. Additionally, "lipolysis," or the process of breaking down fat in the body, may be regulated by enzymes sensitive to temperature, such as HSL ("hormone-sensitive lipase"). Thus, elevating the temperature of the adipose cells may increase the lipolysis rate, and thus contribute to a reduction in subdermal fat in the area being treated. This temperature can be below the temperature for vascular/lymph damage so damaged fatty cells and fatty acids can be easily removed from the treatment region. Additionally, application of the present invention may be used in combination with other fat-reduction techniques, such as medication, exercise, or adrenergic stimulation Heating of subcutaneous fat may also result in increased dermal thickness. Thus, fatty tissue may be replaced by fibrous and dermal tissue, this resulting in improved skin appearance.. . Thermal activation of lymph systems in subcutaneous fat can also be used to treat cellulite by removing proteins from extra cell spaces.
Stated another way, fat and/or cellulite reduction may be achieved utilizing the teachings of this invention by providing an elevated (but below damage threshold ~ 43-48°C) temperature in the targeted region at depth. The mild hyperthermia initiates biological response through one or several of the following pathways:
1. Increase of activity of enzymes regulating the process of lipolysis, in particular, hormone sensitive lipase (HSL). As a result, decrease of fat stores in hypodermis. 2. Stimulation of blood and lymph flow in the targeted area with multiple positive consequences, including (but not limited to) further decrease in the fat stores and accelerated regeneration of connective tissue. 3. Induction of apoptosis in adipocytes, with subsequent removal of residual cell material by the body's scavenging system. 4. Decrease of lipid's viscosity, resulting in increasing mobility of fat globules and permeability of adipocytes' membranes. 5. Stimulation and or reorganization of the connective tissue surrounding subdermal fat depots with or without concurrent changes of the dermal collagen. The net result is a shift of balance between fat and connective tissue in hypodermis toward the latter and improved appearance of skin.
Fig. 1 shows an apparatus 100 for one embodiment of the invention. For this apparatus, optical energy 30 from a suitable energy source 1 passes through optical (for example, focusing) device 2, filter 3, cooling mechanism 4 and contact plate 8, before reaching tissue 31. A suitable optical impedance matching lotion or other suitable substance would typically be applied between plate 8 and tissue 31 to provide enhanced optical and thermal contact. Tissue 31, as shown in Fig. 1, is divided into an upper region 5, which, for applications where radiation is applied to the skin surface, would be the epidermis and dermis, and a lower region 6 which would be a subdermal region in the previous example. Energy 30, possibly in conjunction with one or a combination of focusing from optical device 2, and wavelength selection from filter 3, and with cooling from mechanism 4, results in maximum heating occurring at a selected depth in tissue 31, which depth is, as previously indicated, at or near the junction of regions 5 and 6 or in lower region 6 for this invention. In some embodiments of the invention, certain of these components, such as, for example, filter 3 where a monochromatic source is utilized or optics 2, may not necessarily be present.
In some embodiments of the invention, energy source 1, optical device 2 and/or filter 3 may also require a cooling mechanism. This cooling mechanism may or may not be the same as or connected to cooling mechanism 4 that cools tissue 31 through contact plate 8, as indicated by arrows 32 in Fig. 1. For example, in the embodiment shown in Fig. 1, cooling mechanism 7, shown separately from cooling mechanism 4, is used to cool filter 3. Energy source 1 may be any suitable optical energy source able to produce optical energy 30 at a wavelength that produces heating within tissue 31 at the depth of a desired treatment region. The exact energy source, and the exact energy chosen, may be a function of the tissue 31 to be heated, the depth within the tissue at which treatment is desired and of the absorption of that energy in the desired area to be treated. For example, energy source 1 may be a radiant lamp, a halogen lamp, an incandescent lamp, a arc lamp, a fluorescent lamp, a light emitting diode, a laser (including diode and fiber lasers), the sun or other suitable optical energy source. Energy source 1 may produce electromagnetic radiation, such as near infrared or visible light radiation over a broad spectrum, over a limited spectrum or at a single wavelength, such as would be produced by a light emitting diode or a laser. In certain cases, a narrow spectral source may be preferable, as the wavelength(s) produced by the energy source may be targeted towards a specific tissue type or may be adapted for reaching a selected depth. In other embodiments, a wide spectral source may be preferable, for example, in systems where the wavelength(s) to be applied to the tissue may change, for example, by applying different filters, depending on the application. As previously indicated, in order to minimize both scattering and absorption of the applied optical radiation, the optical radiation produced by energy source 1 should be radiation with a wavelength which is minimally scattered and absorbed, the available wavelengths decreasing with increasing depth as generally indicated in Table 1. Certain wavelengths may be preferentially absorbed by the tissue to be treated. As one example, if the tissue to be treated includes subcutaneous fat, certain wavelengths may be absorbed more effectively by the fat or adipose cells than by the surrounding tissues. For example, optical radiation having wavelengths around 925 nm, 1206 nm, 1730 nm and 2300 nm may be desirable (see for example copending application serial #09/277307, which is incorporated herein by reference, for suitable ranges); however, only the lower three of these ranges would typically provide sufficient penetration for use in practicing this invention. Using electromagnetic radiation of these wavelengths, the coefficient of absorption by this radiation in the lipids, and in particular the triglycerides located within the adipose tissue may be greater than that of the absorption coefficient of these wavelengths in water. Thus, these wavelengths when applied to a tissue sample, will preferentially be absorbed by the fat tissue, thus resulting in the preferential heating of this tissue. The selective heating of the fatty tissue can be enhanced by the lower heat capacity of fatty tissue vs. aqueous tissue. Also, the decreased blood perfusion of the subcutaneous fat vs. the dermis can be used to enhance selective heating of the fatty tissue. Compression sufficient to reduce blood flow within the target area can minimize unwanted heat convection, and therefore heat leakage, from the target area. The compression to the subdermal target area can be made selective by forming a skin fold and applying skin pressure sidewise. This results in compression of the subcutaneous fat and of skin outside the field of optical exposure. The skin on top of the skin fold, which skin is exposed to the optical radiation, is not compressed, and therefore the blood flow therein is not appreciably reduced so long as the length of the skin fold does not exceed a critical length. Blood flow within the part of the dermis exposed to optical radiation can help to remove unwanted excessive heat in this skin component.
Where optical device 2 is a focusing device, it may be any suitable device able to focus at least a portion of energy 30 arriving from energy source 1 at tissue 31, and in particular at a selected depth in tissue 31. For example, device 2 may include mirrors, prisms, reflectors, lenses such as Fresnel lenses, collimating lenses or focusing lenses, diffraction gratings, or other optical device. Filter 3 may be any suitable filter able to select, or at least partially select, certain wavelengths or wavelength bands from energy source 1. In certain types of filters, a specific set of wavelengths may be blocked by the filter. It is also possible that undesired wavelengths in the energy from source 1 may be wavelength shifted in ways known in the art so as to enhance the energy available in the desired wavelength bands indicated above and in Table 1. Thus, filter 3 may include elements designed to absorb, reflect or alter certain wavelengths of electromagnetic radiation. For example, filter 3 may be used to remove certain types of wavelengths that are absorbed by surrounding tissues. For instance, dermis and epidermis tissues are primarily composed of water, as is much of the rest of the human body. By using a filter that selectively removes wavelengths that excite water molecules, the absorption of these wavelengths by the body may be greatly reduced, which may contribute to a reduction in the amount of heat generated by light absorption in these molecules. Thus, by passing radiation through a water-based filter, those frequencies of radiation which may excite water molecules will be absorbed in the water filter, and will not be transmitted into tissue 31. Thus, a water- based filter may be used to decrease the amount of radiation absorbed in tissue above the treatment region and converted into heat.
In other embodiments, filter 3 may be combined with other elements of the device, for example, cooling system 4 or cooling mechanism 7. Thus, water may both attenuate energy 30 arising from energy source 1, as well as cool the contact plate, and tissue in contact with the contact plate, or various other components of the device. More than one filter or filter type may also be present.
Fig. 1 shows a cooling mechanism 4 adjacent to the surface of tissue 31. Cooling mechanism 4 may be any suitable cooling mechanism able to reduce the temperature of tissue 31. Heat energy 32 may be drawn from tissue 31 across contact plate 8 into cooling mechanism 4. For example, cooling system 4 may be air or other suitable gas that is blown over contact plate 8, cooling water, or a cooling oil or other fluid. Mixtures of these substances, such as an oil and water mixture, may also be envisioned. Cooling mechanism 4 may have any suitable configuration, for example, a flat plate, a series of conducting pipes, a sheathing blanket, or a series of channels for the passage of air, or other gases, or liquid across plate 8. For example, in one embodiment, cooling system 4 may be a water-cooled contact plate. In another embodiment, cooling mechanism 4 may be a series of channels carrying a coolant fluid or a refrigerant fluid (for example, a cryogen), which channels are in contact with tissue 31 or with plate 8. In yet another embodiment, cooling system 4 may comprise a water or refrigerant fluid (for example RI 34A) spray, a cool air spray or air flow across the surface of tissue 31. In other embodiments, cooling may be accomplished through chemical reactions (for example, endothermic reactions), or through electronic cooling, such as Peltier cooling. In yet other embodiments, cooling mechanism 4 may have more than one type of coolant, or cooling mechanism 4 and/or contact plate 8 may be absent, for example, in embodiments where the tissue is cooled passively or directly, for example, through a cryogenic or other suitable spray. Sensors or other monitoring devices may also be embedded in cooling mechanism 4, for example, to monitor the temperature, or determine the degree of cooling required by tissue 31, and be manually or electronically controlled. In certain cases, cooling mechanism 4 may be used to maintain the surface temperature of tissue 31 at its normal temperature, which may be, for example, 37 or 32 °C, depending on the type of tissue being heated. In other embodiments, cooling mechanism 4 may be used to decrease the temperature of the surface of tissue 31 to a temperature below the normal temperature of that type of tissue. For example, cooling mechanism 4 may be able to decrease the surface temperature of tissue 31 to, for example, a range between 25 °C and -5 °C.
In some embodiments of the invention, such as shown in Fig. 1, energy 30 from energy source 1 may pass through cooling mechanism 4. In these types of configurations, cooling mechanism 4 may be constructed out of materials able to transmit at least a portion of energy 30, for example, air, water or other gases or fluids, glass, or a clear plastic. In other embodiments, cooling mechanism 4 may be formed out of a series of discrete channels, and energy 30 may pass between these channels. In other embodiments of the invention, energy 30 may not be directed through cooling mechanism 4. For example, in the embodiment shown in Fig. 8, energy source 19 and cooling system 18 may be positioned on opposite sides of chamber 17. Contact plate 8 may be made out of a suitable heat transfer material, and also, where the plate contacts tissue 31, of a material having a good optical match with the tissue. Sapphire is an example of a suitable material for plate 8. In some embodiments, contact plate 8 may have a high degree of thermal conductivity, for example, to allow cooling of the surface of the tissue by cooling mechanism 4. In other embodiments, contact plate 8 may be an integral part of cooling mechanism 4, or be absent. Contact plate 8 may be made out of a deformable or viscoelastic material in some embodiments of the invention, for example, a gel such as a hydrogel. In other embodiments, contact plate 8 may be made of a solid material, such as a glass, a crystal such as sapphire, or a plastic. In some embodiments of the invention, such as shown in Fig. 1 , energy 30 from energy source 1 may pass through contact plate 8. In these configurations, contact plate 8 may be constructed out of materials able to transmit at least a portion of energy 30, for example glass, sapphire, or a clear plastic, or contact plate 8 may be constructed in such a way as to allow at least a portion of energy 30 to pass through contact plate 8, for example, via a series of holes within contact plate 8.
In certain embodiments of the invention, various components of system 100 may require cooling. For example, in the embodiment shown in Fig. 1, optical device 2 and filter 3 may be cooled by cooling mechanism 7. The design of cooling mechanism 7 may be a function of the components used in the construction of the apparatus. Cooling mechanism 7 and cooling mechanism 4, in Fig. 1, are illustrated as separate systems. However, in other embodiments, cooling mechanism 7 and cooling mechanism 4 may be part of the same system, or one or both may be absent. Cooling mechanism 7 may be any suitable cooling mechanism known in the art, such as air, water, or an oil. Mixtures of these substances, such as an oil and water mixture, may also be envisioned. Cooling of the components may be accomplished through convective or conductive cooling.
One or more of energy source 1, optical device 2, filter 3, cooling mechanism 4, or cooling mechanism 7 may be electronically controlled. For example, sensors embedded in cooling mechanism 4 or contact plate 8 may determine the amount of energy reaching tissue 31, and may direct energy source 1 to produce more or less energy or may direct cooling mechanism 4 to increase or decrease cooling, depending on the application. Other sensors and the like may be embedded in any of the components illustrated herein. The controls may be, for example, electronically preprogrammed, or manually operable.
The present invention is not limited to treating a specific region or area of tissue. For example, as illustrated in Figs. 8 and 9, the invention may be constructed in such a way as to treat an entire person. For example, in Fig. 8, chamber 17 contains cooling mechanism 18 and energy source 19. Cooling mechanism 18 may be cooled in the same ways described above for cooling mechanisms 4 and 7. Energy source 19 may contain, for example, a series of lamps or other energy sources, optionally surrounded by filters 40. In this embodiment, filters 40 are built into the side of chamber 17. Fig. 9 shows another design, where chamber 17 has a cooling mechanism 18, but does not contain an energy source. Instead, energy 42 from the sun 41 or another energy source, such as an external lamp, is directed to chamber 17, for example, directly, by means of reflectors 20, or by means of a lens such as Fresnel lens 19. The patient may be cooled within the chamber by air flow or other suitable cooling mechanism 18. In Fig. 2, another embodiment of the invention is shown. In this embodiment, a lamp 9, for example an incandescent lamp, is used as the energy source. Lamp 9 is surrounded by a specially coated reflector 10 to maximize light delivery efficiency to the treatment region of tissue 31 . A fluid 13 may pass between contact plate 8 and filter 3. Contact plate 8, cooled by fluid 13, may cool the surface of the tissue to which it is applied. In Fig. 3, lamp 9 has been replaced by a monochromatic light emitting element 1 1 and lens 12, element 11 being, for example a laser diode, other suitable laser or a light emitting diode. As in the embodiment shown in Fig. 2, contact plate 8 and filter 3 are cooled by fluid 13 flowing therebetween; these two components may also be cooled by flow of cold liquid gas, for example R134A, from a pressurized can. Thus, this embodiment illustrates how a monocromatic element 1 1 may be used as the energy source.
A different type of cooling mechanism is illustrated in Fig. 4. In Fig. 4, energy arising from energy source 1 is reflected using reflector 10 through filter 3, a transparent isolating material 16, and contact plate 8. Two fluids are used to cool the filter and the contact plate. Upper fluid 14 flows between filter 3 and isolating material 16, while lower fluid 15 passes between isolating material 16 and contact plate 8. Fluids 14 and 15, in this embodiment, may not be the same fluid; however, in other embodiments, the two fluids may be the same fluid, or have a common reservoir. Contact plate 8, in this embodiment, may be made out of, for example, a transparent or a semi-transparent material, such as a glass, plastic or sapphire. Alternatively, contact plate 8 may be formed out of an opaque material, but have openings to allow energy to pass through contact plate 8. A similar embodiment of the invention is shown in Fig. 5, where the energy source 1 has been replaced by an element that produces discrete wavelengths, such as a light emitting diode or a laser diode 1 1. Optional lens 12 has also been added to the system as illustrated in Fig. 5. In certain embodiments of the invention, contact plate 8 may be absent. For example, in the embodiment shown in Fig. 6, no contact plate is used, and fluid 13 (for example a liquid, gas such as air or a spray) passes or flows directly over the surface of tissue 31. Legs 42 connected to the device may be constructed in such a manner as to correctly position filter 3 over the surface of the tissue. Legs 42 may be any component able to maintain a proper distance between the surface of tissue 31 and device 100. In some embodiments of the invention, legs 42 may be constructed out of a flexible or a semi-solid substance that, for example, may conform to the surface of tissue 31, such as a gel. In other embodiments of the invention, legs 42 may be constructed out of a solid substance, such as rubber or plastic. Legs 42 may have any arrangement underneath the device that allows for the proper positioning of the device relative to the tissue. For example, legs 42 may be arranged in a triangular or a square pattern. In other embodimeηts of the invention, legs 42 may be a ring or a series of bars that surrounds the area being treated or legs 42 may be absent. More than one device 100 of this invention may be used simultaneously. For example, in Fig. 7, a series of devices 100 have been arranged into a semicircular pattern. These devices may be linked together to treat large areas of a subject's body. Additionally, the devices may be interconnected in such a way as to provide flexibility, so that, for example, the apparatus may conform to the contours of the body. For example, the device may be worn as a belt, a leg wrap, an arm wrap, or wrapped around the torso. Devices 100 may also be mounted to a chair, bed or other suitable surface for the treatment of a patient's back, thighs and/or buttocks. Alternatively, devices 100 may be used to create an array of small island areas within a larger area (see for example copending application serial 10/033,302 which is incorporated herein by reference). This may, for example, be a safer alternative to large area heating, particularly for extended treatment regimens. By optimizing the spacing between treated areas, for example, through the addition of "masks" in filter 3 between energy source 1 and tissue 31 that block portions of the energy arising from energy source 1, and/or through the use of multiple separate devices 100 as is shown in Fig. 7, treatment of the subdermal tissue may be maximized, while causing a minimal amount of patient discomfort, and/or allowing faster recovery time. Where optical source 1 is a continuous wave (CW) or other long duration source, device 100 for various of the embodiments may be slid or scanned over the surface of the patient's skin to overlie successive treatment regions, the dwell time, and thus the treatmentduration, for each such region being a function of the rate at which the device is movedThe device may also include a cooling mechanism ahead of the portion of the device under source 1 to precool skin above the treatment region (see for example issued U.S. Patents Nos. 6,273,884 and 6,511,475, which are incorporated herein by reference).
Any of the embodiments can include a contact sensor to assure good optical and thermal coupling, and systems operating in the sliding mode may also include one or more motion sensors to control radiation delivery, cooling and other functions dependent on scanning speed, to enhance system safety and for other reasons.
In addition to coupling the deep heating treatment of this invention with deep cooling to enhance treatment of fat, bone, muscle, etc., device 100 may also include a massager, vibrator or other mechanical stimulation device or a DC or other suitable electrical stimulation source. It has been found that such mechanical or electrical stimulation is more effective for hot tissue. Similarly, the effect of deep heating may be enhanced by massage or other stimulation because both heat and cold generally penetrates better in compressed skin and subdermal tissue. Thus, the combination of deep heating and mechanical or electrical stimulation may provide significantly better results then either one alone. Heating may also be enhanced by supplementing the optical heating with, for example electro-stimulation by AC/DC, or additional heating by RF, etc. Tensioning or pressure applied to the skin overlying the treatment region may also enhance treatment effect.
The teachings of this invention may also be utilized for hair removal treatments by targeting the hair bulb, which is generally located in the subcutaneous layer 6. The treatment would be done at low power sufficient to raise the temperature of the fat surrounding the hair bulb, and thus the hair bulb, to roughly 45°C and should be performed for a relatively long time period, for example, 15 minutes. The hair bulb also contains high proliferation water cells which react strongly with the applied radiation to increase bulb temperature, leading to the destruction thereof.
The function and advantages of these and other embodiments of the present invention will be more fully understood from the following examples. These examples are intended to be only illustrative in nature and are not intended to limit the scope of the invention.
Example 1
This example illustrates theoretical calculations corresponding to one embodiment of the invention as applied to human skin.
Initially, a model of the skin was prepared. This model included two layers of tissue possessing distinct optical and thermal properties: dermis and subcutaneous fat (Fig. 10). The presence of fine structures such as the basal layer and the vessel plexus was neglected. Monochromatic light was assumed to be incident normal to the surface. The input power density was designated as Fp. Both the surface temperature (Ts) at depth z=0 and the bottom temperature (7h ) at depth z=h were kept fixed at prescribed levels. Specifically, 7Η was set at 37 °C due to the temperature stabilization effect of blood and metabolic heat generation on muscle tissue. The objective of this example was to evaluate the steady-state temperature distribution within the skin and to find the characteristic depth zmax where the steady-state temperature reaches a maximum. Starting with the problem of light transport within the tissue, scattering in both tissue layers predominated strongly over absorption, allowing the diffuse approximation to be applied. This approach was particularly valid within the wavelength range of 600 nm to 1400 nm, which may also be referred to as the "therapeutic window". The one-dimensional light transport problem in the diffusion approximation for the two-layered tissue model of Fig. 10 can be solved assuming both the tissue irradiance and the light flux to be the continuous functions of coordinate z at the dermis and fat interface. The resulting expression for the tissue irradiance, ψ, obtained may be written in the following general form:
(1 ) FQ - τcol
Figure imgf000018_0001
exp(- κλ - z)+ V2 - exp(*τ , - z)- V3 - exp(- μt
Figure imgf000018_0002
z ≤ hd , ψι z) = F0 τcol [V4 exp(- κ2
Figure imgf000018_0003
z > hd
where indices 1 and 2 stand for dermis and subcutaneous fat, respectively. κ v ' ^a ' ^lr and + . are the diffusion and extinction coefficients for light in the corresponding
4n,«2
T..., =
( + V layers, and v"ι + n ) is the attenuation coefficient of the collimated light at the surface.
Flux amplitudes V\ to V$ were determined by the boundary and interface conditions. In particular, if the coefficients of refraction of both layers are the same, the interface condition at z = hd is such that both the radiance and the total light flux should be continuous functions of depth. Turning to the problem of heat conduction within the two-layered tissue model, the time dependent equation of heat conduction in the A th layer was:
^-T{z,t) = ak ^TT{z,t)+ Qk(z,t), ot dz (2) yielding the following steady-state equation:
ak ^T(z) = -Qk (z), dz (3) where ak was the thermal diffusivity of the &-th layer (k = 1,2). The heat source term ^ in these equations describes the generation of heat due to light absorption in the tissue. In the steady-state case, the source term is:
Figure imgf000019_0001
where μak, pk and cjtare the coefficient of absorption, density, and specific heat of the A th layer, respectively.
Boundary conditions were assumed to be T(0) = Ts,T(h) = 7/,. The solution of Equation (3) was then found to be:
7 (z) = T, + B {h - z) - — • dz' dz"Q(z"),
Figure imgf000019_0002
where parameters A and B have to be found from the interface conditions. For the case of perfect thermal contact: c)- T2{hd), kι — l (hd )= k2 —T2(hd ), dz dz (6)
where and k\ and &2 are the thermal conductivities of dermis and fat, respectively.
The analytic expression for the temperature, T(z), was then obtained by substituting Equation (3) into Equations (4) and (5). A simpler expression for the temperature distribution was obtained for a homogenous medium with no layered structure. In this case, the radiance distribution took the following general form:
ψ(z) =
Figure imgf000019_0003
where the first term was the collimated radiance and the second one was the diffuse radiance given by:
Ψd (z) = V2 exp(- κ - z)- V - exp(- μ,z). (8)
The temperature distribution was:
Figure imgf000020_0001
Differentiating Equation (9) with respect to z yields the following implicit expression for the depth zmax, the localized tissue depth at which maximum temperature occurs:
Figure imgf000020_0002
Tmax =Th - Ts is maximum temperature rise in the tissue at the depth zmax.
Equation (10) was solved numerically. To get an approximate analytic expression, the inequality μt » /rwas used, which is typically valid within the therapeutic window. Then, dropping the exponential terms with μt, and solving the simplified equation with respect to zmax yielded the following
zraax
Figure imgf000020_0003
Maximum temperature can be calculated from (9) as Tmax =T(zmax)
It can be seen from these results that an increase in Eo caused the temperature maximum to move upwards, provided the input flux is sufficiently small. At larger value of Eo, the maximum ceased to move while proceeding to grow in amplitude. The treatment time should be long enough to remove heat from the layer 0 < z < zmaχ This time tmm was given by the formula:
Figure imgf000021_0001
where / is the depth into dermis and z2 is depth into subcutaneous fat, and z\ + z2 = z is depth of treatment The numerator constant (6÷60) varies within the given range depending on how close the desired temperature is to Tmax, being 6 for Tzmax = 90% Tmax and 60 for Tzmax=99% Tmax. The treatment time must be longer than tmιn. Fig. 1 1 shows a typical temperature distribution in the body. Fig. 13 and Table 2 show minimum treatment time as a function of depth of treatment z.
Equations (10), (1 1), and (12) describe a set of heating and cooling parameters that allow control of both the value and location of the internal temperature maximum. Fig. 1 1 shows a graph generated using these equations that shows that a broad spectral source, having a proper set of filters, combined with surface cooling, allows the temperature within the adipose layer of tissue to be elevated to a maximum, while maintaining acceptable temperatures surrounding tissue and in particular, in tissue above the treatment region through which the radiation passes.
Thus, this example illustrates theoretical calculations corresponding to one embodiment of the invention.
Example 2
The following prophetic example illustrates treatment parameters for different body layers that may be used in one embodiment of the invention, as applied to human skin.
Based on the calculation illustrated in Example 1, treatment parameters for different layers of the body that may be used in one embodiment of the invention can be determined. These calculations are summarized in Table 1. The body layers model includes the reticular dermis, dermis subcutaneous fat junction, and subcutaneous fat layer.
Using a broad-spectrum lamp in this embodiment of the invention, the treatment parameters include a surface cooling mechanism able to maintain a surface cooling temperature of between 0 °C and 32 °C; a broad-spectrum lamp, where the color temperature of the lamp is between 300 K and 3000 K, with filtering of more than 50% of the light having wavelengths of less than 800 nm and greater that 1800 nm, preferably 900 to 1400 nm, and most preferably 1 100 to 1250 nm . Depending on depth, the treatment being performed and other factors, the power may vary from approximately 0.2 to 50 W/cm2, and more preferably from approximately 0.5 to 20 W/cm2, with a treatment time of between 2 sec for a 1mm depth and 7300 sec for a 50 mm depth When operating in sliding mode, treatment power and duration increase.
Thus, this prophetic example illustrates exemplary treatment parameters that may be used to heat different layers of the body, in one embodiment of the invention.
Figure imgf000023_0001
Table 2. Minimum treatment time without precooling
Figure imgf000024_0001
Example 3 In this example, a device 100 of this invention substantially as shown in Fig.2 was used to heat subcutaneous fat in the stomach region of a volunteer. Light from a halogen lamp 9 was filtered with a combination of a short cut or high pass filter 8 with an 800 nm cut-off and a 3 mm thick water layer 41. The temperature of water 41 was 12°C, while the temperature of a sapphire plate 8 and of the skin interface was 18°C. Power density was 4W/cm2 and the treatment time was 300 sec. After heating the subcutaneous fat layer for 300 sec, the device was removed, and two thermocouples were immediately implanted 1 mm and 8 mm below the skin surface under the heated region to determine the final, steady-state temperatures and to monitor the temperature relaxation profiles in the dermis and fat layer respectively. Temperature data recorded by the two thermocouples are shown in Fig. 12. The initial temperature of the subcutaneous fat layer at a depth of 8 mm was found to be approximately 45 °C, while the temperature of the dermis, 1 mm below the surface of the skin, was found to be about 40 °C and the temperature at the epidermis was 24°C. Over the course of the next several minutes, the temperatures of the dermis and the subcutaneous fat layer decreased towards basal levels of 37 °C for the subcutaneous fat layer and approximately 32 °C for the dermis. '
The same device 100 was used to perform the same test on a 25 mm bulk of pig skin and subcutaneous fat which was placed on a thermally stable plate with a temperature of 37°C. The power density for this test was 10 W/cm2 and cooling water having a temperature of 4°C was used. After a treatment time of 300 se , peak temperature of 53°Cwas found at a depth 14 mm into the fat. The temperature at the epidermis at this time was 38°C. After about 6 weeks, this exposure setting induced reduction of subcutaneous fat without evidence for epidermal damage. A partial replacement of fatty tissue by connective collagen tissue was observed. A reduction of hair growth was also observed several weeks after this and similar exposure settings, even if a lower temperature rise was obtained and only a single treatment was performed. This clearly emphasized the possibility of using this method to manage unwanted hair growth. Highly proliferating cells like sebocytes within the sebaceous glands or hair matrix cells within the hair follicle are particularly sensitive to heating which can be used to achieve selective effects on these structures even by unselective heating of the depth were these structures are located. Hair matrix cells are also surrounded by fatty cells and the sebaceous glands are generating lipids. The decreased heat capacity for lipids provides additional selective effects. This can also be specifically useful for the treatment of non pigmented hairs that are usually not affected by standard light assisted methods for photoepilation based on selective photothermolysis. Hair growth management may include permanent or temporary hair removal or merely controlling/slowing hair growth rate.
These examples thus illustrates how a device of the invention may be used to heat a subdermal layer of tissue to a temperature significantly higher than normal body temperature and the temperature of surrounding tissue, including tissue between the skin surface and the treatment region..
While several embodiments of the invention have been described and illustrated herein, those of ordinary skill in the art will readily envision a variety of other means and structures for performing the functions and/or obtaining the results and/or advantages described herein, and each of such variations or modifications is deemed to be within the scope of the present invention. More generally, those skilled in the art would readily appreciate that all parameters, dimensions, materials, and configurations described herein are meant to be exemplary and that actual parameters, dimensions, materials, and configurations will depend upon specific applications for which the teachings of the present invention are used. Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. It is, therefore, to be understood that the foregoing embodiments are presented by way of example only and that, within the scope of the appended claims and equivalents thereto, the invention may be practiced otherwise than as specifically described. The present invention is directed to each individual feature, system, material and/or method described herein. In addition, any combination of two or more such features, systems, materials and/or methods, if such features, systems, materials and/or methods are not mutually inconsistent, is included within the scope of the present invention. In the claims, all transitional phrases or phrases of inclusion, such as "comprising," "including," "carrying," "having," "containing," and the like are to be understood to be open-ended, i.e. to mean "including but not limited to." Only the transitional phrases or phrases of inclusion "consisting of and "consisting essentially of are to be interpreted as closed or semi-closed phrases, respectively.
What is claimed is:

Claims

1. Apparatus for treating at least a selected region at depth of a patient while protecting tissue above the selected region, comprising: an optical radiation source for delivering optical radiation at a power of between
0.2-50W/cm2 to the patient's skin, said power varying at least in part as a function of the depth of said selected region, said optical radiation being applied to said selected region for at least approximately 2 seconds; and a cooling mechanism for cooling tissue above said selected region to a temperature below that of said selected region.
2. Apparatus as claimed in claim 1 wherein said power is 0.5-20W/cm2.
3. Apparatus as claimed in claim 1 wherein said power is 0.5-5W/cm2.
4. Apparatus as claimed in claim 1 wherein said source includes a broadband optical radiation source, and a filter through which radiation from said broadband source is passed.
5. Apparatus as claimed in claim 4 wherein said filter includes a water filter to at least attenuate wavelengths from said broadband source which are selectively absorbed by water.
6. Apparatus as claimed in claim 5 wherein said water filter includes chilled water flowing between said broadband source and the patient's body, said flowing chilled water also functioning as part of said mechanism for cooling.
7. Apparatus as claimed in claim 4 wherein said cooling mechanism also cools said filter.
8. Apparatus as claimed in claim 4 including a mechanism for removing heat from said filter.
9. Apparatus as claimed in claim 1 wherein said source includes optics for shaping radiation to be delivered to said selected region.
10. Apparatus as claimed in claim 1 wherein said source is at least primarily at one or more wavelengths between about 600 nm and about 1850 nm.
11. Apparatus as claimed in claim 10 wherein said source is at least primarily at one or more wavelengths between about 800 nm and about 1350 nm.
12. Apparatus as claimed in claim 10 wherein said source is at least primarily at one or more wavelengths between about 1050 nm and about 1250 nm.
13. Apparatus as claimed in claim 1 wherein said optical radiation source and said mechanism are concurrently operated for a period of at least two seconds.
14. Apparatus as claimed in claim 13 wherein said optical radiation source and said mechanism are concurrently operated for a period of at least five seconds.
15. Apparatus as claimed in claim 1 wherein said optical radiation source and said mechanism are concurrently operated for a period of between about two seconds and two hours.
16. Apparatus as claimed in claim 13 including a precooling mechanism which cools tissue above said selected region prior to the concurrent operation of said source and said cooling mechanism.
17. Apparatus as claimed in claim 16 wherein said cooling mechanism and said precooling mechanism are the same mechanism.
18. Apparatus as claimed in claim 16 wherein said optical radiation power and said period of concurrent operation vary dependent on whether said precooling mechanism is operated.
19. Apparatus as claimed in claim 1 wherein parameters for said optical radiation source and for said cooling mechanism are selected to achieve a selected temperature as indicated by equation 10 at a selected depth z max determined by equation 11.
20. Apparatus as claimed in claim 19 wherein the minimum treatment time for the apparatus is determined in accordance with equation 12.
21. Apparatus as claimed in claim 1 wherein said apparatus is an apparatus for fat reduction, said radiation heating subdermal fat tissue.
22. Apparatus as claimed in claim 1 including a mechanism for stimulating tissue in said selected region.
23. Apparatus as claimed in claim 22 wherein said mechanism for providing stimulation is at least one of a mechanical stimulator, acoustic stimulator and an electrical stimulator.
24. Apparatus as claimed in claim 1 wherein said selected region contains at least one hair bulb, and wherein parameters for said apparatus, including said source, are selected to slowly damage said bulb.
25. A method for treating at least a selected region at depth of a patient's body while protecting tissue above the selected region, comprising:
(a) selectively delivering optical radiation at a power between approximately 0.2 and 50 W/cm2 to the patient's body above said selected region, said power varying at least in part as a function of the depth of said selected region, said optical radiation being applied to said selected region for at least approximately 2 seconds; and
(b) concurrently cooling patient tissue above said selected region to a temperature below that of the selected region.
26. A method as claimed in claim 25 wherein said power is 0.5-20 W/cm2.
27. A method as claimed in claim 25 wherein said power is 0.5-5 W/cm2.
28. A method as claimed in claim 25 wherein step (a) includes generating broad band optical radiation, and filtering said broad band radiation before delivering it to said patient's body.
29. A method as claimed in claim 25 wherein said method is a method for fat reduction, said radiation heating subdermal fat tissue.
30. A method as claimed in claim 25 wherein said method is a method for performing therapy on at least one of subdermal muscle, ligament and bone, said radiation causing heating of such muscle/ligament/bone and of tissue in the area thereof to at least increase blood flow in such area.
31. A method as claimed in claim 25 wherein said method is a method for treating a selected unwanted growth, said radiation heating said growth sufficiently to cause the destruction thereof.
32. The method of claim 25, wherein the electromagnetic energy is at least primarily at one or more wavelengths between about 600 nm and about 1850 nm.
33. The method of claim 32, wherein the electromagnetic energy is at least primarily at one or more wavelengths between about 800 nm and about 13500 nm.
34. The method of claim 32 wherein the electromagnetic energy is at least primarily at one or more wavelengths between about 1050 nm and about 1250 nm.
35. The method of claim 25 wherein step (a) and step (b) are performed concurrently for a period of at least two seconds.
36. The method of claim 35 wherein step (a) and step (b) are performed concurrently for a period of at least five seconds.
37. The method of claim 25 wherein step (a) and step (b) are performed concurrently for a period of between about two seconds and about two hours.
38. The method of claim 25 including the step of precooling tissue above said selected region.
39. The method of claim 38 wherein said optical radiation power and said period of concurrent operation vary dependent on whether said precooling step is performed.
40. The method of claim 25 wherein said selected region is heated during step (a).
41. The method of claim 25 wherein parameters for said optical radiation and for said cooling are selected to achieve a selected temperature as indicated by equation 10 at a selected depth z max determined by equation 1 1.
42. The method of claim 41 wherein the minimum treatment time for the method is determined in accordance with equation 12.
43. The method of claim 25 wherein said method is a method for fat reduction, subdermal fat tissue being heated during step (a).
44. The method of claim 25 including the step of stimulating tissue in said selected region.
45. The method of claim 44 wherein said step of providing stimulation provides at least one of mechanical stimulation, acoustic stimulation and electrical stimulation.
46. The method of claim 25 wherein said selected region contains at least one hair bulb, and wherein parameters for said method, including said radiation, are selected to slowly damage said bulb.
47. A method for treating at least a selected region at depth of a patient's body while protecting tissue above the selected region, comprising:
(a) selectively delivering radiation to the patient's body above said selected region to heat the region;
(b) concurrently cooling patient tissue above said selected region to a temperature below that of the selected region; and
(c) applying at least one of mechanical, acoustic and electrical stimulation to said region.
48. A method for treating at least a selected region at depth of a patient's body while protecting tissue above the selected region, comprising:
(a) selectively delivering radiation to the patient's body above said selected region to heat the region, said radiation being selected so as not to be scattered or absorbed by tissue above said selected region sufficiently to prevent sufficient radiation from reaching the selected region to effect a desired treatment; and
(b) concurrently cooling patient tissue above said selected region to a temperature below that of the selected region.
49. A method as claimed in claim 48 wherein said selected region contains subdermal fat; and wherein said radiation at least includes at least one wavelength selectively absorbed by fat.
50. A method for hair management comprising:
(a) selectively delivering radiation to the patient's body above a region of subdermal fat containing a bulb for a hair to be removed to heat the region and thus the hair bulb, resulting in damage thereto; and
(b) concurrently cooling patient tissue above said region to a temperature below that of the region.
PCT/US2003/019474 2002-06-19 2003-06-19 Method and apparatus for photothermal treatment of tissue at depth WO2004000150A1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
PCT/US2003/019474 WO2004000150A1 (en) 2002-06-19 2003-06-19 Method and apparatus for photothermal treatment of tissue at depth
EP03737199A EP1523283A1 (en) 2002-06-19 2003-06-19 Method and apparatus for photothermal treatment of tissue at depth
BR0311901-7A BR0311901A (en) 2002-06-19 2003-06-19 Process and apparatus for photothermal deep tissue treatment
US10/465,137 US7351252B2 (en) 2002-06-19 2003-06-19 Method and apparatus for photothermal treatment of tissue at depth
CA2487987A CA2487987C (en) 2002-06-19 2003-06-19 Method and apparatus for photothermal treatment of tissue at depth
JP2004516013A JP2006500972A (en) 2002-06-19 2003-06-19 Method and apparatus for treating tissue at a depth by radiant heat
AU2003238302A AU2003238302B2 (en) 2002-06-19 2003-06-19 Method and apparatus for photothermal treatment of tissue at depth
CNB038140454A CN100482182C (en) 2002-06-19 2003-06-19 Method and apparatus for photothermal treatment of tissue at depth
IL197542A IL197542A (en) 2002-06-19 2004-11-28 Method and apparatus for photothermal treatment of tissue at depth
IL165418A IL165418A (en) 2002-06-19 2004-11-28 Apparatus for photothermal treatment of tissue at depth
HK06100339.4A HK1080341A1 (en) 2002-06-19 2006-01-09 Method and apparatus for photothermal treatment of tissue at depth

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38987102P 2002-06-19 2002-06-19
US60/389,871 2002-06-19
PCT/US2003/019474 WO2004000150A1 (en) 2002-06-19 2003-06-19 Method and apparatus for photothermal treatment of tissue at depth

Publications (1)

Publication Number Publication Date
WO2004000150A1 true WO2004000150A1 (en) 2003-12-31

Family

ID=36602703

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/019474 WO2004000150A1 (en) 2002-06-19 2003-06-19 Method and apparatus for photothermal treatment of tissue at depth

Country Status (10)

Country Link
US (1) US7351252B2 (en)
EP (1) EP1523283A1 (en)
JP (1) JP2006500972A (en)
CN (1) CN100482182C (en)
AU (1) AU2003238302B2 (en)
BR (1) BR0311901A (en)
CA (1) CA2487987C (en)
HK (1) HK1080341A1 (en)
IL (2) IL165418A (en)
WO (1) WO2004000150A1 (en)

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006076506A2 (en) * 2005-01-13 2006-07-20 Candela Corporation Treating a diseased nail
WO2006089227A2 (en) * 2005-02-18 2006-08-24 Palomar Medical Technologies, Inc. Dermatological treatment device
US7255560B2 (en) 2002-12-02 2007-08-14 Nomir Medical Technologies, Inc. Laser augmented periodontal scaling instruments
EP1983888A2 (en) * 2006-01-24 2008-10-29 Nomir Medical Technologies, Inc Optical method and device for modulation of biochemical processes in adipose tissue
US7470124B2 (en) 2003-05-08 2008-12-30 Nomir Medical Technologies, Inc. Instrument for delivery of optical energy to the dental root canal system for hidden bacterial and live biofilm thermolysis
WO2010007419A1 (en) * 2008-07-14 2010-01-21 Virulite Distribution Limited Electromagnetic radiation therapy
US7763016B2 (en) 1997-05-15 2010-07-27 Palomar Medical Technologies, Inc. Light energy delivery head
GB2470927A (en) * 2009-06-10 2010-12-15 Dezac Group Ltd Phototherapy apparatus with skin temperature control
US7935107B2 (en) 1997-05-15 2011-05-03 Palomar Medical Technologies, Inc. Heads for dermatology treatment
US7942915B2 (en) 2002-05-23 2011-05-17 Palomar Medical Technologies, Inc. Phototreatment device for use with coolants
US8182473B2 (en) 1999-01-08 2012-05-22 Palomar Medical Technologies Cooling system for a photocosmetic device
US8328794B2 (en) 1996-12-02 2012-12-11 Palomar Medical Technologies, Inc. System for electromagnetic radiation dermatology and head for use therewith
US8346347B2 (en) 2005-09-15 2013-01-01 Palomar Medical Technologies, Inc. Skin optical characterization device
US8506979B2 (en) 2002-08-28 2013-08-13 Nomir Medical Technologies, Inc. Near-infrared electromagnetic modification of cellular steady-state membrane potentials
WO2013090058A3 (en) * 2011-12-12 2013-11-07 Candela Corporation Devices for the treatment of biological tissue
US8814922B2 (en) 2009-07-22 2014-08-26 New Star Lasers, Inc. Method for treatment of fingernail and toenail microbial infections using infrared laser heating and low pressure
US8888830B2 (en) 2012-09-10 2014-11-18 Dermal Photonics Corporation Systems and methods for usage replenishment
US8915948B2 (en) 2002-06-19 2014-12-23 Palomar Medical Technologies, Llc Method and apparatus for photothermal treatment of tissue at depth
US9028536B2 (en) 2006-08-02 2015-05-12 Cynosure, Inc. Picosecond laser apparatus and methods for its operation and use
US9108044B2 (en) 2005-06-14 2015-08-18 Virulite Distribution Limited Use of electromagnetic radiation in the treatment of sensory organs
USD747800S1 (en) 2013-09-10 2016-01-19 Dermal Photonics Corporation Dermatological medical device
US9314302B2 (en) 2004-06-24 2016-04-19 Virulite Llc Cosmetic uses of electromagnetic radiation
US9780518B2 (en) 2012-04-18 2017-10-03 Cynosure, Inc. Picosecond laser apparatus and methods for treating target tissues with same
US9919168B2 (en) 2009-07-23 2018-03-20 Palomar Medical Technologies, Inc. Method for improvement of cellulite appearance
WO2018211492A1 (en) 2017-05-18 2018-11-22 Lightfective Ltd. Methods and devices for treatment of subcutaneous fat
US10245107B2 (en) 2013-03-15 2019-04-02 Cynosure, Inc. Picosecond optical radiation systems and methods of use
US10434324B2 (en) 2005-04-22 2019-10-08 Cynosure, Llc Methods and systems for laser treatment using non-uniform output beam
US11418000B2 (en) 2018-02-26 2022-08-16 Cynosure, Llc Q-switched cavity dumped sub-nanosecond laser

Families Citing this family (209)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189230B2 (en) * 1996-01-05 2007-03-13 Thermage, Inc. Method for treating skin and underlying tissue
US7452358B2 (en) * 1996-01-05 2008-11-18 Thermage, Inc. RF electrode assembly for handpiece
US20030212393A1 (en) * 1996-01-05 2003-11-13 Knowlton Edward W. Handpiece with RF electrode and non-volatile memory
US6104959A (en) 1997-07-31 2000-08-15 Microwave Medical Corp. Method and apparatus for treating subcutaneous histological features
AUPP176898A0 (en) * 1998-02-12 1998-03-05 Moldflow Pty Ltd Automated machine technology for thermoplastic injection molding
US20020156471A1 (en) * 1999-03-09 2002-10-24 Stern Roger A. Method for treatment of tissue
US7534255B1 (en) 2003-01-24 2009-05-19 Photothera, Inc Low level light therapy for enhancement of neurologic function
US7303578B2 (en) * 2001-11-01 2007-12-04 Photothera, Inc. Device and method for providing phototherapy to the brain
US8308784B2 (en) * 2006-08-24 2012-11-13 Jackson Streeter Low level light therapy for enhancement of neurologic function of a patient affected by Parkinson's disease
US10695577B2 (en) * 2001-12-21 2020-06-30 Photothera, Inc. Device and method for providing phototherapy to the heart
US7316922B2 (en) * 2002-01-09 2008-01-08 Photothera Inc. Method for preserving organs for transplant
US8840608B2 (en) 2002-03-15 2014-09-23 The General Hospital Corporation Methods and devices for selective disruption of fatty tissue by controlled cooling
CN110522505B (en) 2002-03-15 2023-04-25 总医院公司 System for selective destruction of adipose tissue by controlled cooling
US20040126272A1 (en) * 2002-08-28 2004-07-01 Eric Bornstein Near infrared microbial elimination laser system
US20080131968A1 (en) * 2002-08-28 2008-06-05 Nomir Medical Technologies, Inc. Near-infrared electromagnetic modification of cellular steady-state membrane potentials
US20040156743A1 (en) * 2002-08-28 2004-08-12 Eric Bornstein Near infrared microbial elimination laser system
US7713294B2 (en) * 2002-08-28 2010-05-11 Nomir Medical Technologies, Inc. Near infrared microbial elimination laser systems (NIMEL)
US20070219604A1 (en) * 2006-03-20 2007-09-20 Palomar Medical Technologies, Inc. Treatment of tissue with radiant energy
US20070213792A1 (en) * 2002-10-07 2007-09-13 Palomar Medical Technologies, Inc. Treatment Of Tissue Volume With Radiant Energy
ES2570987T3 (en) * 2003-02-25 2016-05-23 Tria Beauty Inc Dermatological treatment device, based on diode laser and autonomous
WO2004075731A2 (en) * 2003-02-25 2004-09-10 Spectragenics, Inc. Acne treatment device and method
US7981111B2 (en) 2003-02-25 2011-07-19 Tria Beauty, Inc. Method and apparatus for the treatment of benign pigmented lesions
EP2604215B1 (en) 2003-02-25 2017-10-11 Tria Beauty, Inc. Eye-safe dermatologic treatment apparatus and method
US7250045B2 (en) * 2003-02-25 2007-07-31 Spectragenics, Inc. Self-contained, eye-safe hair-regrowth-inhibition apparatus and method
US7452356B2 (en) * 2003-02-25 2008-11-18 Tria Beauty, Inc. Eye-safe dermatologic treatment apparatus
US7413567B2 (en) * 2003-02-25 2008-08-19 Spectragenics, Inc. Optical sensor and method for identifying the presence of skin
WO2004080279A2 (en) * 2003-03-06 2004-09-23 Spectragenics, Inc. In the patent cooperation treaty application for patent
EP2277470B1 (en) * 2003-03-27 2013-10-09 The General Hospital Corporation Apparatus for dermatological treatment and fractional skin resurfacing
CA2525892A1 (en) * 2003-05-16 2004-12-02 Waverx, Inc. Apparatus and method for the treatment of infectious disease in keratinized tissue
US7291140B2 (en) * 2003-07-18 2007-11-06 Cutera, Inc. System and method for low average power dermatologic light treatment device
US8870856B2 (en) 2003-08-25 2014-10-28 Cutera, Inc. Method for heating skin using light to provide tissue treatment
US8915906B2 (en) * 2003-08-25 2014-12-23 Cutera, Inc. Method for treatment of post-partum abdominal skin redundancy or laxity
US7722600B2 (en) 2003-08-25 2010-05-25 Cutera, Inc. System and method for heating skin using light to provide tissue treatment
US7326199B2 (en) * 2003-12-22 2008-02-05 Cutera, Inc. System and method for flexible architecture for dermatologic treatments utilizing multiple light sources
US7282060B2 (en) * 2003-12-23 2007-10-16 Reliant Technologies, Inc. Method and apparatus for monitoring and controlling laser-induced tissue treatment
US7184184B2 (en) * 2003-12-31 2007-02-27 Reliant Technologies, Inc. High speed, high efficiency optical pattern generator using rotating optical elements
WO2005065565A1 (en) * 2003-12-31 2005-07-21 Palomar Medical Technologies, Inc. Dermatological treatment with vusualization
US7372606B2 (en) * 2003-12-31 2008-05-13 Reliant Technologies, Inc. Optical pattern generator using a single rotating component
FR2864903B1 (en) * 2004-01-14 2006-09-15 Optical System Res For Industr APPARATUS FOR THE TREATMENT, IN PARTICULAR BY LASER, OF A CANCER OR PRECANCEROUS CONDITION
EP1718366A4 (en) 2004-02-06 2007-11-21 Daniel Barolet Method and device for the treatment of mammalian tissues
US20050256553A1 (en) * 2004-02-09 2005-11-17 John Strisower Method and apparatus for the treatment of respiratory and other infections using ultraviolet germicidal irradiation
US8777935B2 (en) 2004-02-25 2014-07-15 Tria Beauty, Inc. Optical sensor and method for identifying the presence of skin
US8257416B2 (en) * 2004-02-25 2012-09-04 Vanderschuit Carl R Therapeutic devices and methods for applying therapy
US7052167B2 (en) * 2004-02-25 2006-05-30 Vanderschuit Carl R Therapeutic devices and methods for applying therapy
JP5065005B2 (en) 2004-04-01 2012-10-31 ザ ジェネラル ホスピタル コーポレイション Method and apparatus for dermatological treatment and tissue remodeling
JP2007536987A (en) * 2004-05-13 2007-12-20 ウェイブレクス,インコーポレイテッド Apparatus and method for treating infectious disease of keratinized tissue
US7837675B2 (en) 2004-07-22 2010-11-23 Shaser, Inc. Method and device for skin treatment with replaceable photosensitive window
US20060036300A1 (en) * 2004-08-16 2006-02-16 Syneron Medical Ltd. Method for lypolisis
USPP16588P2 (en) * 2004-11-17 2006-05-30 Koji Goto Petunia plant named ‘Temari’
US7425296B2 (en) 2004-12-03 2008-09-16 Pressco Technology Inc. Method and system for wavelength specific thermal irradiation and treatment
US10857722B2 (en) * 2004-12-03 2020-12-08 Pressco Ip Llc Method and system for laser-based, wavelength specific infrared irradiation treatment
US7780656B2 (en) * 2004-12-10 2010-08-24 Reliant Technologies, Inc. Patterned thermal treatment using patterned cryogen spray and irradiation by light
KR20070086176A (en) * 2004-12-22 2007-08-27 더 지렛트 캄파니 Reduction of hair growth
US20060200212A1 (en) * 2005-02-17 2006-09-07 Brawn Peter R Light therapy device for treatment of bone disorders and biostimulation of bone and soft tissue
US20070248930A1 (en) 2005-02-17 2007-10-25 Biolux Research Ltd. Light therapy apparatus and methods
WO2006093384A1 (en) * 2005-03-02 2006-09-08 Meridian Co., Ltd. Adipose resolve apparatus for low-power laser
US20060265034A1 (en) * 2005-04-05 2006-11-23 Ams Medical Sa Microwave devices for treating biological samples and tissue and methods for using same
US20060229689A1 (en) * 2005-04-08 2006-10-12 Led Technologies, Llc LED therapy device
AU2006272766A1 (en) * 2005-07-21 2007-02-01 Nomir Medical Technologies, Inc. Near infrared microbial elimination laser system (NIMELS)
US20070176262A1 (en) * 2005-08-11 2007-08-02 Ernest Sirkin Series connection of a diode laser bar
US20070173799A1 (en) * 2005-09-01 2007-07-26 Hsia James C Treatment of fatty tissue adjacent an eye
WO2007038567A1 (en) * 2005-09-28 2007-04-05 Candela Corporation Treating cellulite
US20070078502A1 (en) * 2005-10-05 2007-04-05 Thermage, Inc. Method and apparatus for estimating a local impedance factor
US20070083190A1 (en) * 2005-10-11 2007-04-12 Yacov Domankevitz Compression device for a laser handpiece
US7957815B2 (en) * 2005-10-11 2011-06-07 Thermage, Inc. Electrode assembly and handpiece with adjustable system impedance, and methods of operating an energy-based medical system to treat tissue
US8702691B2 (en) * 2005-10-19 2014-04-22 Thermage, Inc. Treatment apparatus and methods for delivering energy at multiple selectable depths in tissue
US20070106109A1 (en) * 2005-11-10 2007-05-10 Ly Van B Device for Stone Therapy and Sexual Stimulation
US20080102107A1 (en) * 2005-12-16 2008-05-01 Valex Pharmaceuticals, Llc Compositions and methods for transdermal joint pain therapy
WO2007073024A2 (en) 2005-12-23 2007-06-28 Max Engineering Ltd. Method of curing inflammatory acne by using carbon lotion and pulsed laser
US7891362B2 (en) * 2005-12-23 2011-02-22 Candela Corporation Methods for treating pigmentary and vascular abnormalities in a dermal region
US8540703B2 (en) 2005-12-23 2013-09-24 Lutronic Corporation Methods for treating skin conditions using laser
US8033284B2 (en) 2006-01-11 2011-10-11 Curaelase, Inc. Therapeutic laser treatment
US10357662B2 (en) 2009-02-19 2019-07-23 Pthera LLC Apparatus and method for irradiating a surface with light
US7575589B2 (en) 2006-01-30 2009-08-18 Photothera, Inc. Light-emitting device and method for providing phototherapy to the brain
US20090254154A1 (en) 2008-03-18 2009-10-08 Luis De Taboada Method and apparatus for irradiating a surface with pulsed light
CN101404950B (en) * 2006-02-01 2015-08-19 通用医疗公司 For utilize conformal laser therapy procedures to monitor and obtain sample at least one part information and the method and system of electromagnetic radiation is provided at least one part of sample
KR100742973B1 (en) * 2006-02-22 2007-07-27 주식회사 루트로닉 Fatty tissue removing using 1444nm beam oscillating nd:yag laser
US7854754B2 (en) 2006-02-22 2010-12-21 Zeltiq Aesthetics, Inc. Cooling device for removing heat from subcutaneous lipid-rich cells
KR100649890B1 (en) * 2006-03-27 2006-11-28 주식회사 루트로닉 Control method and control structure of laser beam irradiation by using a contact sensor
US7662177B2 (en) 2006-04-12 2010-02-16 Bacoustics, Llc Apparatus and methods for pain relief using ultrasound waves in combination with cryogenic energy
US20070255362A1 (en) * 2006-04-28 2007-11-01 Juniper Medical, Inc. Cryoprotectant for use with a cooling device for improved cooling of subcutaneous lipid-rich cells
US20070282318A1 (en) * 2006-05-16 2007-12-06 Spooner Gregory J Subcutaneous thermolipolysis using radiofrequency energy
US20080009844A1 (en) * 2006-06-26 2008-01-10 Ingeborg Rolle Device for Laser Surgery
CN101610735B (en) * 2006-06-28 2015-07-01 美敦力Af卢森堡公司 Methods and systems for thermally-induced renal neuromodulation
US20080045933A1 (en) * 2006-08-15 2008-02-21 Paul Perl Multi-broadband pulse emitter and a method for applying an effective dermal treatment
US20080161745A1 (en) * 2006-09-08 2008-07-03 Oliver Stumpp Bleaching of contrast enhancing agent applied to skin for use with a dermatological treatment system
US9132031B2 (en) 2006-09-26 2015-09-15 Zeltiq Aesthetics, Inc. Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US8192474B2 (en) * 2006-09-26 2012-06-05 Zeltiq Aesthetics, Inc. Tissue treatment methods
US20100049180A1 (en) * 2007-10-19 2010-02-25 Lockheed Martin Corporation System and method for conditioning animal tissue using laser light
WO2008091983A2 (en) * 2007-01-25 2008-07-31 Thermage, Inc. Treatment apparatus and methods for inducing microburn patterns in tissue
US20080221649A1 (en) * 2007-03-09 2008-09-11 Agustina Echague Method of sequentially treating tissue
US8202268B1 (en) 2007-03-18 2012-06-19 Lockheed Martin Corporation Method and multiple-mode device for high-power short-pulse laser ablation and CW cauterization of bodily tissues
US20090024003A1 (en) * 2007-03-28 2009-01-22 N.V. Organon Accurate method to assess disease severity in clinical trials concerning psychopathology
WO2008127641A1 (en) * 2007-04-11 2008-10-23 Eleme Medical Inc. Use of low intensity light therapy for the treatment of various medical conditions
US9241763B2 (en) 2007-04-19 2016-01-26 Miramar Labs, Inc. Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
CN101711134B (en) 2007-04-19 2016-08-17 米勒玛尔实验室公司 Tissue is applied the system of microwave energy and in organized layer, produces the system of tissue effect
US9149331B2 (en) 2007-04-19 2015-10-06 Miramar Labs, Inc. Methods and apparatus for reducing sweat production
US20100211059A1 (en) 2007-04-19 2010-08-19 Deem Mark E Systems and methods for creating an effect using microwave energy to specified tissue
JP2010524589A (en) 2007-04-19 2010-07-22 ザ ファウンドリー, インコーポレイテッド Method, apparatus and system for non-invasive delivery of microwave therapy
US20090036956A1 (en) * 2007-04-30 2009-02-05 Victor Alexeevich Mikhalylov Laser treatment system and related methods
US20080287839A1 (en) 2007-05-18 2008-11-20 Juniper Medical, Inc. Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator
US20090012515A1 (en) * 2007-07-06 2009-01-08 Hoenig Peter A Devices, systems and methods for treating tissues
US8216218B2 (en) * 2007-07-10 2012-07-10 Thermage, Inc. Treatment apparatus and methods for delivering high frequency energy across large tissue areas
US20090018625A1 (en) * 2007-07-13 2009-01-15 Juniper Medical, Inc. Managing system temperature to remove heat from lipid-rich regions
US20090018626A1 (en) * 2007-07-13 2009-01-15 Juniper Medical, Inc. User interfaces for a system that removes heat from lipid-rich regions
US8523927B2 (en) 2007-07-13 2013-09-03 Zeltiq Aesthetics, Inc. System for treating lipid-rich regions
US20090018624A1 (en) * 2007-07-13 2009-01-15 Juniper Medical, Inc. Limiting use of disposable system patient protection devices
JP2009034234A (en) * 2007-07-31 2009-02-19 Panasonic Electric Works Co Ltd Light emitter for controlling hair growth
JP2009034235A (en) * 2007-07-31 2009-02-19 Panasonic Electric Works Co Ltd Light emitter for controlling hair growth
JP5179110B2 (en) * 2007-07-31 2013-04-10 パナソニック株式会社 Hair growth control light irradiation device
EP2194899A4 (en) * 2007-08-08 2012-11-28 Tria Beauty Inc Capacitive sensing method and device for detecting skin
US8285390B2 (en) 2007-08-21 2012-10-09 Zeltiq Aesthetics, Inc. Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue
JP2010075639A (en) * 2007-10-19 2010-04-08 Shiseido Co Ltd Method and apparatus for improving skin condition of face and neck
JP6008463B2 (en) * 2007-12-07 2016-10-19 ザ ジェネラル ホスピタル コーポレイション System and apparatus for dermatological treatment
AU2008335715B2 (en) 2007-12-12 2014-01-23 Miradry, Inc. Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
ES2471971T3 (en) 2007-12-12 2014-06-27 Miramar Labs, Inc. System and apparatus for non-invasive treatment of tissue using microwave energy
US7896908B2 (en) * 2008-01-08 2011-03-01 Oregon Aesthetic Technologies Skin therapy system
US8540702B2 (en) * 2008-03-11 2013-09-24 Shaser, Inc. Enhancing the brightness of optical radiation used in light-based dermatologic treatment systems
JP5628792B2 (en) 2008-04-25 2014-11-19 トリア ビューティ インコーポレイテッド Optical sensor and method for distinguishing skin presence and skin pigmentation
US7848035B2 (en) 2008-09-18 2010-12-07 Photothera, Inc. Single-use lens assembly
WO2010036732A1 (en) * 2008-09-25 2010-04-01 Zeltiq Aesthetics, Inc. Treatment planning systems and methods for body contouring applications
US9532717B2 (en) * 2008-10-28 2017-01-03 The Procter & Gamble Company Method for diagnosing vulvovaginal disorders
US20110190749A1 (en) * 2008-11-24 2011-08-04 Mcmillan Kathleen Low Profile Apparatus and Method for Phototherapy
AU2009316273A1 (en) * 2008-11-24 2010-05-27 Gradiant Research, Llc Photothermal treatment of soft tissues
US8603073B2 (en) 2008-12-17 2013-12-10 Zeltiq Aesthetics, Inc. Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
US20100234737A1 (en) * 2009-03-12 2010-09-16 Miranda Aref Farage Method for assessing skin irritation using infrared light
US20100234925A1 (en) * 2009-03-16 2010-09-16 PinPoint U.S.A., Inc. Treatment of microbiological pathogens in a toe nail with antimicrobial light
US8399731B2 (en) * 2009-03-19 2013-03-19 Covidien Lp Phototherapy wound treatment
JP5566451B2 (en) * 2009-04-22 2014-08-06 レイディアンシー インコーポレイテッド Skin treatment device using light and temperature
KR101871659B1 (en) 2009-04-30 2018-08-02 젤티크 애스세틱스, 인코포레이티드. Device, system and method of removing heat from subcutaneous lipid-rich cells
ES2746877T3 (en) * 2009-09-16 2020-03-09 Univ Texas Modification of the temperature in the body of a mammal
JP2011110134A (en) * 2009-11-25 2011-06-09 Panasonic Electric Works Co Ltd Light irradiation device
US20110190745A1 (en) * 2009-12-04 2011-08-04 Uebelhoer Nathan S Treatment of sweat glands
US20110172746A1 (en) * 2010-01-12 2011-07-14 Roger Porter High Level Laser Therapy Apparatus and Methods
WO2011091431A1 (en) 2010-01-25 2011-07-28 Zeltiq Aesthetics, Inc. Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associated devices, systems and methods
US9308046B2 (en) * 2010-05-18 2016-04-12 Candela Corporation Reduction of pain through lower fluence rates and longer treatment times
US8676338B2 (en) 2010-07-20 2014-03-18 Zeltiq Aesthetics, Inc. Combined modality treatment systems, methods and apparatus for body contouring applications
CN103037938B (en) 2010-08-17 2016-05-25 皇家飞利浦电子股份有限公司 Flexible phototherapy device, plaster and bandage
CN101912669B (en) * 2010-08-31 2013-05-22 清华大学 Surface-cooling non-invasive radiation whole-body thermocuring method
EP2624777B1 (en) 2010-10-07 2019-03-20 Gradiant Research, Llc Apparatus for skin cancer thermal therapy
JP2014503255A (en) * 2010-12-03 2014-02-13 サイノシュア・インコーポレーテッド Non-invasive fat reduction with thermal treatment
EP2648651B1 (en) 2010-12-08 2016-11-23 Biolux Research Limited Apparatuses useful for regulating bone remodeling or tooth movement using light therapy and a functional appliance
WO2012103242A1 (en) 2011-01-25 2012-08-02 Zeltiq Aesthetics, Inc. Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells
US9314301B2 (en) 2011-08-01 2016-04-19 Miramar Labs, Inc. Applicator and tissue interface module for dermatological device
US9078587B2 (en) * 2011-10-21 2015-07-14 The Regents Of The University Of California Method and apparatus for photomagnetic imaging
US20160220834A1 (en) * 2011-11-16 2016-08-04 Btl Holdings Limited Method and system for skin treatment
US9498641B2 (en) 2012-03-05 2016-11-22 Blue Water Innovations, Llc Fat reducing device and method utilizing optical emitters
DE102012013534B3 (en) 2012-07-05 2013-09-19 Tobias Sokolowski Apparatus for repetitive nerve stimulation for the degradation of adipose tissue by means of inductive magnetic fields
US9993658B2 (en) 2012-08-16 2018-06-12 Yolo Medical Inc. Light applicators, systems and methods
US9844460B2 (en) 2013-03-14 2017-12-19 Zeltiq Aesthetics, Inc. Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same
US9545523B2 (en) 2013-03-14 2017-01-17 Zeltiq Aesthetics, Inc. Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue
EP2968925B1 (en) 2013-03-14 2020-02-19 Cynosure, LLC Electrosurgical systems
EP2967711B1 (en) 2013-03-15 2020-05-06 Cynosure, LLC Electrosurgical instruments with multimodes of operation
WO2015013502A2 (en) 2013-07-24 2015-01-29 Miramar Labs, Inc. Apparatus and methods for the treatment of tissue using microwave energy
JP6112416B2 (en) * 2013-09-06 2017-04-12 パナソニックIpマネジメント株式会社 Light irradiation device for body hair
CN105682603A (en) 2013-10-22 2016-06-15 碧奥鲁克斯研究有限公司 Intra-oral light-therapy apparatuses and methods for their use
EP3065823B1 (en) 2013-11-06 2020-09-09 Terry Ward Cellulite and fat reducing device and method utilizing optical emitters
US9949889B2 (en) 2013-11-11 2018-04-24 Joylux, Inc. At-home light-emitting diode and massage device for vaginal rejuvenation
EP3099259A1 (en) 2014-01-31 2016-12-07 Zeltiq Aesthetics, Inc. Treatment systems and methods for affecting glands and other targeted structures
US10675176B1 (en) 2014-03-19 2020-06-09 Zeltiq Aesthetics, Inc. Treatment systems, devices, and methods for cooling targeted tissue
USD777338S1 (en) 2014-03-20 2017-01-24 Zeltiq Aesthetics, Inc. Cryotherapy applicator for cooling tissue
US10952891B1 (en) 2014-05-13 2021-03-23 Zeltiq Aesthetics, Inc. Treatment systems with adjustable gap applicators and methods for cooling tissue
US10935174B2 (en) 2014-08-19 2021-03-02 Zeltiq Aesthetics, Inc. Stress relief couplings for cryotherapy apparatuses
US10568759B2 (en) 2014-08-19 2020-02-25 Zeltiq Aesthetics, Inc. Treatment systems, small volume applicators, and methods for treating submental tissue
US9907975B1 (en) 2014-11-19 2018-03-06 Roger D. Porter Therapeutic laser treatment and transdermal stimulation of stem cell differentiation
US10518104B2 (en) 2015-04-23 2019-12-31 Cynosure, Llc Systems and methods of unattended treatment
US10737109B2 (en) 2015-04-23 2020-08-11 Cynosure, Llc Systems and methods of unattended treatment of a subject's head or neck
US11491342B2 (en) 2015-07-01 2022-11-08 Btl Medical Solutions A.S. Magnetic stimulation methods and devices for therapeutic treatments
US10695575B1 (en) 2016-05-10 2020-06-30 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US20180001107A1 (en) 2016-07-01 2018-01-04 Btl Holdings Limited Aesthetic method of biological structure treatment by magnetic field
US11266850B2 (en) 2015-07-01 2022-03-08 Btl Healthcare Technologies A.S. High power time varying magnetic field therapy
US10478634B2 (en) 2015-07-01 2019-11-19 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10569094B2 (en) 2015-07-01 2020-02-25 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10821295B1 (en) 2015-07-01 2020-11-03 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10569095B1 (en) 2015-07-01 2020-02-25 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10709894B2 (en) 2015-07-01 2020-07-14 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10695576B2 (en) 2015-07-01 2020-06-30 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10179085B2 (en) * 2015-10-02 2019-01-15 Joylux, Inc. Light-emitting diode and massage device for delivering focused light for vaginal rejuvenation
WO2017070112A1 (en) 2015-10-19 2017-04-27 Zeltiq Aesthetics, Inc. Vascular treatment systems, cooling devices, and methods for cooling vascular structures
JP7125117B2 (en) * 2015-10-26 2022-08-24 オーハイ レチナル テクノロジー,エルエルシー Method for thermally treating biological tissue using a pulsed energy source
US11253717B2 (en) 2015-10-29 2022-02-22 Btl Healthcare Technologies A.S. Aesthetic method of biological structure treatment by magnetic field
EP3399950A1 (en) 2016-01-07 2018-11-14 Zeltiq Aesthetics, Inc. Temperature-dependent adhesion between applicator and skin during cooling of tissue
US10765552B2 (en) 2016-02-18 2020-09-08 Zeltiq Aesthetics, Inc. Cooling cup applicators with contoured heads and liner assemblies
JP6600415B2 (en) * 2016-03-29 2019-10-30 ダブル エイチ リミテッド Wearable device for reducing body fat using LED and method of operating the same
KR102499714B1 (en) 2016-04-11 2023-02-14 싸이노슈어, 엘엘씨 Unmanned treatment system and method for subject's head or neck
US11464993B2 (en) 2016-05-03 2022-10-11 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11247039B2 (en) 2016-05-03 2022-02-15 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11382790B2 (en) 2016-05-10 2022-07-12 Zeltiq Aesthetics, Inc. Skin freezing systems for treating acne and skin conditions
US10555831B2 (en) 2016-05-10 2020-02-11 Zeltiq Aesthetics, Inc. Hydrogel substances and methods of cryotherapy
US10682297B2 (en) 2016-05-10 2020-06-16 Zeltiq Aesthetics, Inc. Liposomes, emulsions, and methods for cryotherapy
US11534619B2 (en) 2016-05-10 2022-12-27 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US10583287B2 (en) 2016-05-23 2020-03-10 Btl Medical Technologies S.R.O. Systems and methods for tissue treatment
US10556122B1 (en) 2016-07-01 2020-02-11 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US11141219B1 (en) 2016-08-16 2021-10-12 BTL Healthcare Technologies, a.s. Self-operating belt
EP3981349A3 (en) 2016-11-22 2022-08-10 Dominion Aesthetic Technologies, Inc. Systems and methods for aesthetic treatment
CN106730402A (en) * 2017-01-05 2017-05-31 海南瑞韩医学美容医院管理有限公司海口龙华京华城红妆医学美容门诊部 A kind of hand for treating chloasma has
US11076879B2 (en) 2017-04-26 2021-08-03 Zeltiq Aesthetics, Inc. Shallow surface cryotherapy applicators and related technology
EP3634290B1 (en) 2017-06-07 2024-01-24 Cynosure, LLC System for fat reduction and improving skin laxity
US11400308B2 (en) 2017-11-21 2022-08-02 Cutera, Inc. Dermatological picosecond laser treatment systems and methods using optical parametric oscillator
CA3089137A1 (en) 2018-02-07 2019-08-15 Cynosure, Inc. Methods and apparatus for controlled rf treatments and rf generator system
JP2021532873A (en) 2018-07-31 2021-12-02 ゼルティック エステティックス インコーポレイテッド Methods, devices, and systems to improve skin properties
EP3721939B1 (en) 2019-04-11 2022-07-06 BTL Healthcare Technologies a.s. Device for aesthetic treatment of biological structures by radiofrequency and magnetic energy
USD1005484S1 (en) 2019-07-19 2023-11-21 Cynosure, Llc Handheld medical instrument and docking base
CN111150939A (en) * 2019-11-18 2020-05-15 西安交通大学 Treatment device based on 940nm wavelength laser
US11253720B2 (en) 2020-02-29 2022-02-22 Cutera, Inc. Dermatological systems and methods with handpiece for coaxial pulse delivery and temperature sensing
US10864380B1 (en) 2020-02-29 2020-12-15 Cutera, Inc. Systems and methods for controlling therapeutic laser pulse duration
US11878167B2 (en) 2020-05-04 2024-01-23 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
KR20230000081U (en) 2020-05-04 2023-01-10 비티엘 헬쓰케어 테크놀로지스 에이.에스. Device and method for unattended treatment of patients
US11896816B2 (en) 2021-11-03 2024-02-13 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2199453A1 (en) * 1972-05-12 1974-04-12 Busser Francis
AU1851583A (en) * 1982-08-27 1984-03-01 Alistair Joseph Blake Lamp for irradiating tumours
EP0724894A2 (en) * 1995-02-03 1996-08-07 ESC Medical Systems Ltd. Method and apparatus for therapeutic electromagnetic treatment
WO1999049937A1 (en) * 1998-03-27 1999-10-07 The General Hospital Corporation Method and apparatus for the selective targeting of lipid-rich tissues
US20010041886A1 (en) * 1999-12-10 2001-11-15 Durkin Anthony J. Method of treating disorders associated with sebaceous follicles

Family Cites Families (170)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE346723A (en) 1926-11-13
US2472385A (en) 1946-07-18 1949-06-07 Michael A Rollman Massage device
US3327712A (en) 1961-09-15 1967-06-27 Ira H Kaufman Photocoagulation type fiber optical surgical device
US3538919A (en) 1967-04-07 1970-11-10 Gregory System Inc Depilation by means of laser energy
US3527932A (en) 1967-11-16 1970-09-08 James J Thomas Transilluminating flashlight
US3486070A (en) 1968-04-29 1969-12-23 Westinghouse Electric Corp Solid-state constant power ballast for electric discharge device
US3622743A (en) 1969-04-28 1971-11-23 Hrand M Muncheryan Laser eraser and microwelder
US4456872A (en) 1969-10-27 1984-06-26 Bose Corporation Current controlled two-state modulation
US3693623A (en) 1970-12-25 1972-09-26 Gregory System Inc Photocoagulation means and method for depilation
US3846811A (en) 1972-03-29 1974-11-05 Canon Kk Flash unit for use with camera
US3818914A (en) 1972-04-17 1974-06-25 Spectroderm Inc Apparatus and method for treatment of skin disorders
US3857015A (en) 1972-11-08 1974-12-24 O Richardson Electrically heated heat sealing implement
US3834391A (en) 1973-01-19 1974-09-10 Block Carol Ltd Method and apparatus for photoepilation
US3900034A (en) 1974-04-10 1975-08-19 Us Energy Photochemical stimulation of nerves
GB1485908A (en) 1974-05-21 1977-09-14 Nath G Apparatus for applying light radiation
US4273109A (en) 1976-07-06 1981-06-16 Cavitron Corporation Fiber optic light delivery apparatus and medical instrument utilizing same
JPS55129327A (en) 1979-03-28 1980-10-07 Minolta Camera Co Ltd Constant intensity light emitting strobe device
GB2071500B (en) * 1980-02-27 1984-03-21 Nath G Coagulator
US4316467A (en) 1980-06-23 1982-02-23 Lorenzo P. Maun Control for laser hemangioma treatment system
US4388924A (en) 1981-05-21 1983-06-21 Weissman Howard R Method for laser depilation
JPS5886179A (en) 1981-11-18 1983-05-23 松下電器産業株式会社 Laser medical apparatus
US4461294A (en) 1982-01-20 1984-07-24 Baron Neville A Apparatus and process for recurving the cornea of an eye
GB2123287B (en) 1982-07-09 1986-03-05 Anna Gunilla Sutton Depilaton device
US4524289A (en) 1983-04-11 1985-06-18 Xerox Corporation Flash lamp power supply with reduced capacitance requirements
US4591762A (en) 1983-05-31 1986-05-27 Olympus Optical, Co. Electronic flash
JPS60123818A (en) 1983-12-08 1985-07-02 Olympus Optical Co Ltd Optical transmitter
US4608978A (en) 1983-09-26 1986-09-02 Carol Block Limited Method and apparatus for photoepiltion
US5140984A (en) 1983-10-06 1992-08-25 Proclosure, Inc. Laser healing method and apparatus
US5108388B1 (en) 1983-12-15 2000-09-19 Visx Inc Laser surgery method
JPS60148567A (en) 1984-01-13 1985-08-05 株式会社東芝 Laser treatment apparatus
IL75998A0 (en) 1984-08-07 1985-12-31 Medical Laser Research & Dev C Laser system for providing target tissue specific energy deposition
EP0215878B1 (en) 1985-03-29 1989-11-08 Eugène Jim POLITZER Method and apparatus for shaving the beard
US5196004A (en) 1985-07-31 1993-03-23 C. R. Bard, Inc. Infrared laser catheter system
US4917084A (en) 1985-07-31 1990-04-17 C. R. Bard, Inc. Infrared laser catheter system
US5137530A (en) 1985-09-27 1992-08-11 Sand Bruce J Collagen treatment apparatus
GB2184021A (en) 1985-12-13 1987-06-17 Micra Ltd Laser treatment apparatus for port wine stains
US4695697A (en) 1985-12-13 1987-09-22 Gv Medical, Inc. Fiber tip monitoring and protection assembly
FR2597744A1 (en) 1986-04-29 1987-10-30 Boussignac Georges CARDIO-VASCULAR CATHETER FOR LASER SHOOTING
EP0272325A1 (en) 1986-06-30 1988-06-29 MEDICAL LASER RESEARCH Co., LTD. Semiconductor laser therapeutic apparatus
US4926227A (en) 1986-08-01 1990-05-15 Nanometrics Inc. Sensor devices with internal packaged coolers
US4749913A (en) 1987-04-17 1988-06-07 General Electric Company Operating circuit for a direct current discharge lamp
US4745909A (en) 1987-05-15 1988-05-24 Pelton Robert J Cold massage tool and method of use thereof
US4860744A (en) 1987-11-02 1989-08-29 Raj K. Anand Thermoelectrically controlled heat medical catheter
US4930504A (en) 1987-11-13 1990-06-05 Diamantopoulos Costas A Device for biostimulation of tissue and method for treatment of tissue
US4860172A (en) 1988-01-19 1989-08-22 Biotronics Associates, Inc. Lamp-based laser simulator
US5242437A (en) 1988-06-10 1993-09-07 Trimedyne Laser Systems, Inc. Medical device applying localized high intensity light and heat, particularly for destruction of the endometrium
US4884560A (en) 1988-07-11 1989-12-05 Kuracina Thomas C Thermal massage device
US4928038A (en) 1988-09-26 1990-05-22 General Electric Company Power control circuit for discharge lamp and method of operating same
US4945239A (en) 1989-03-29 1990-07-31 Center For Innovative Technology Early detection of breast cancer using transillumination
US5263951A (en) 1989-04-21 1993-11-23 Kerus Medical Systems Correction of the optical focusing system of the eye using laser thermal keratoplasty
US5057104A (en) 1989-05-30 1991-10-15 Cyrus Chess Method and apparatus for treating cutaneous vascular lesions
US5486172A (en) 1989-05-30 1996-01-23 Chess; Cyrus Apparatus for treating cutaneous vascular lesions
US5182557A (en) 1989-09-20 1993-01-26 Semborg Recrob, Corp. Motorized joystick
DE3936367A1 (en) 1989-11-02 1991-05-08 Simon Pal SHAVER
FR2655849B1 (en) 1989-12-19 1997-10-31 Raymond Bontemps LOCAL CRYOGENIC DEVICE FOR MASSAGE OF THE SKIN.
SE465953B (en) 1990-04-09 1991-11-25 Morgan Gustafsson DEVICE FOR TREATMENT OF UNDESECTED EXTERNAL ACCOMMODATIONS
US5059192A (en) 1990-04-24 1991-10-22 Nardo Zaias Method of hair depilation
US5071417A (en) 1990-06-15 1991-12-10 Rare Earth Medical Lasers, Inc. Laser fusion of biological materials
US5549660A (en) 1990-11-15 1996-08-27 Amron, Ltd. Method of treating acne
US5065515A (en) 1991-01-24 1991-11-19 Warner-Lambert Company Thermally assisted shaving system
US5300097A (en) 1991-02-13 1994-04-05 Lerner Ethan A Fiber optic psoriasis treatment device
US5207671A (en) 1991-04-02 1993-05-04 Franken Peter A Laser debridement of wounds
US5474549A (en) 1991-07-09 1995-12-12 Laserscope Method and system for scanning a laser beam for controlled distribution of laser dosage
US5178617A (en) 1991-07-09 1993-01-12 Laserscope System for controlled distribution of laser dosage
US5225926A (en) 1991-09-04 1993-07-06 International Business Machines Corporation Durable optical elements fabricated from free standing polycrystalline diamond and non-hydrogenated amorphous diamond like carbon (dlc) thin films
US5267399A (en) 1991-09-09 1993-12-07 Johnston William A Implement for simultaneous skin chilling and chilled gel application
US5370642A (en) 1991-09-25 1994-12-06 Keller; Gregory S. Method of laser cosmetic surgery
US5817089A (en) * 1991-10-29 1998-10-06 Thermolase Corporation Skin treatment process using laser
US5226907A (en) 1991-10-29 1993-07-13 Tankovich Nikolai I Hair removal device and method
US5425728A (en) 1991-10-29 1995-06-20 Tankovich; Nicolai I. Hair removal device and method
US5871480A (en) * 1991-10-29 1999-02-16 Thermolase Corporation Hair removal using photosensitizer and laser
US5344418A (en) * 1991-12-12 1994-09-06 Shahriar Ghaffari Optical system for treatment of vascular lesions
US5275596A (en) 1991-12-23 1994-01-04 Laser Centers Of America Laser energy delivery tip element with throughflow of vaporized materials
IL100545A (en) 1991-12-29 1995-03-15 Dimotech Ltd Apparatus for photodynamic therapy treatment
US5405368A (en) 1992-10-20 1995-04-11 Esc Inc. Method and apparatus for therapeutic electromagnetic treatment
US5334191A (en) 1992-05-21 1994-08-02 Dix Phillip Poppas Laser tissue welding control system
DE69311478T2 (en) 1992-09-07 1998-01-02 Philips Electronics Nv Method for producing a block-shaped carrier body for a semiconductor component
US5720772A (en) * 1992-10-20 1998-02-24 Esc Medical Systems Ltd. Method and apparatus for therapeutic electromagnetic treatment
US5683380A (en) 1995-03-29 1997-11-04 Esc Medical Systems Ltd. Method and apparatus for depilation using pulsed electromagnetic radiation
US5620478A (en) 1992-10-20 1997-04-15 Esc Medical Systems Ltd. Method and apparatus for therapeutic electromagnetic treatment
US6280438B1 (en) * 1992-10-20 2001-08-28 Esc Medical Systems Ltd. Method and apparatus for electromagnetic treatment of the skin, including hair depilation
US5334193A (en) 1992-11-13 1994-08-02 American Cardiac Ablation Co., Inc. Fluid cooled ablation catheter
US5707403A (en) * 1993-02-24 1998-01-13 Star Medical Technologies, Inc. Method for the laser treatment of subsurface blood vessels
DE9303352U1 (en) * 1993-03-08 1993-07-22 Elfo Ag Sachseln, Sachseln, Ch
US5304170A (en) 1993-03-12 1994-04-19 Green Howard A Method of laser-induced tissue necrosis in carotenoid-containing skin structures
US5350376A (en) 1993-04-16 1994-09-27 Ceramoptec, Inc. Optical controller device
US5403306A (en) 1993-06-22 1995-04-04 Vanderbilt University Laser surgery method
US5860967A (en) * 1993-07-21 1999-01-19 Lucid, Inc. Dermatological laser treatment system with electronic visualization of the area being treated
US5415654A (en) 1993-10-05 1995-05-16 S.L.T. Japan Co., Ltd. Laser balloon catheter apparatus
US5458140A (en) 1993-11-15 1995-10-17 Non-Invasive Monitoring Company (Nimco) Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers
US5885211A (en) * 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
US5413587A (en) 1993-11-22 1995-05-09 Hochstein; Peter A. Infrared heating apparatus and methods
US5358503A (en) 1994-01-25 1994-10-25 Bertwell Dale E Photo-thermal therapeutic device and method
US5616140A (en) 1994-03-21 1997-04-01 Prescott; Marvin Method and apparatus for therapeutic laser treatment
US5505726A (en) 1994-03-21 1996-04-09 Dusa Pharmaceuticals, Inc. Article of manufacture for the photodynamic therapy of dermal lesion
JP3263275B2 (en) * 1994-04-05 2002-03-04 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Apparatus for laser treatment of living tissue and laser treatment apparatus for flame-like nevus
US5519534A (en) 1994-05-25 1996-05-21 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Irradiance attachment for an optical fiber to provide a uniform level of illumination across a plane
US5531740A (en) 1994-09-06 1996-07-02 Rapistan Demag Corporation Automatic color-activated scanning treatment of dermatological conditions by laser
US5531739A (en) 1994-09-23 1996-07-02 Coherent, Inc. Method of treating veins
US5522813A (en) 1994-09-23 1996-06-04 Coherent, Inc. Method of treating veins
US5662643A (en) 1994-09-28 1997-09-02 Abiomed R & D, Inc. Laser welding system
US5735884A (en) * 1994-10-04 1998-04-07 Medtronic, Inc. Filtered feedthrough assembly for implantable medical device
AT403654B (en) * 1994-12-01 1998-04-27 Binder Michael Dr DEVICE FOR THE OPTICAL EXAMINATION OF HUMAN SKIN AND THE SAME ASSIGNMENT EVALUATION DEVICE
US5558667A (en) 1994-12-14 1996-09-24 Coherent, Inc. Method and apparatus for treating vascular lesions
US5595568A (en) 1995-02-01 1997-01-21 The General Hospital Corporation Permanent hair removal using optical pulses
US5735844A (en) * 1995-02-01 1998-04-07 The General Hospital Corporation Hair removal using optical pulses
US5868731A (en) * 1996-03-04 1999-02-09 Innotech Usa, Inc. Laser surgical device and method of its use
US5885273A (en) * 1995-03-29 1999-03-23 Esc Medical Systems, Ltd. Method for depilation using pulsed electromagnetic radiation
US5660836A (en) 1995-05-05 1997-08-26 Knowlton; Edward W. Method and apparatus for controlled contraction of collagen tissue
DE29508077U1 (en) * 1995-05-16 1995-08-10 Wilden Lutz Dr Med Oral care device
US5879376A (en) * 1995-07-12 1999-03-09 Luxar Corporation Method and apparatus for dermatology treatment
US5658323A (en) 1995-07-12 1997-08-19 Miller; Iain D. Method and apparatus for dermatology treatment
US6350276B1 (en) * 1996-01-05 2002-02-26 Thermage, Inc. Tissue remodeling apparatus containing cooling fluid
US5630811A (en) 1996-03-25 1997-05-20 Miller; Iain D. Method and apparatus for hair removal
US5742392A (en) * 1996-04-16 1998-04-21 Seymour Light, Inc. Polarized material inspection apparatus
US5662644A (en) 1996-05-14 1997-09-02 Mdlt, Inc. Dermatological laser apparatus and method
US5743901A (en) * 1996-05-15 1998-04-28 Star Medical Technologies, Inc. High fluence diode laser device and method for the fabrication and use thereof
US5655547A (en) 1996-05-15 1997-08-12 Esc Medical Systems Ltd. Method for laser surgery
US6183434B1 (en) * 1996-07-03 2001-02-06 Spectrx, Inc. Multiple mechanical microporation of skin or mucosa
US6096029A (en) * 1997-02-24 2000-08-01 Laser Skin Toner, Inc. Laser method for subsurface cutaneous treatment
US6214034B1 (en) * 1996-09-04 2001-04-10 Radiancy, Inc. Method of selective photothermolysis
US6026828A (en) * 1996-09-10 2000-02-22 Altshuler; Gregory B. Toothbrush
US6653618B2 (en) * 2000-04-28 2003-11-25 Palomar Medical Technologies, Inc. Contact detecting method and apparatus for an optical radiation handpiece
US6015404A (en) * 1996-12-02 2000-01-18 Palomar Medical Technologies, Inc. Laser dermatology with feedback control
US6517532B1 (en) * 1997-05-15 2003-02-11 Palomar Medical Technologies, Inc. Light energy delivery head
US7204832B2 (en) * 1996-12-02 2007-04-17 Pálomar Medical Technologies, Inc. Cooling system for a photo cosmetic device
US6162211A (en) * 1996-12-05 2000-12-19 Thermolase Corporation Skin enhancement using laser light
US5830208A (en) * 1997-01-31 1998-11-03 Laserlite, Llc Peltier cooled apparatus and methods for dermatological treatment
US5891063A (en) * 1997-04-03 1999-04-06 Vigil; Arlene Skin rejuvinating system
JP4056091B2 (en) * 1997-05-15 2008-03-05 パロマー・メディカル・テクノロジーズ・インコーポレーテッド Dermatological treatment method and apparatus
US6030399A (en) * 1997-06-04 2000-02-29 Spectrx, Inc. Fluid jet blood sampling device and methods
US5883471A (en) * 1997-06-20 1999-03-16 Polycom, Inc. Flashlamp pulse shaper and method
US5885274A (en) * 1997-06-24 1999-03-23 New Star Lasers, Inc. Filament lamp for dermatological treatment
WO2000053261A1 (en) * 1999-03-08 2000-09-14 Asah Medico A/S An apparatus for tissue treatment and having a monitor for display of tissue features
US6176854B1 (en) * 1997-10-08 2001-01-23 Robert Roy Cone Percutaneous laser treatment
FR2772274B1 (en) * 1997-12-16 2002-01-04 Galderma Rech Dermatologique DEVICE COMPRISING A CHROMOPHORE COMPOSITION FOR APPLICATION ON THE SKIN, METHOD FOR MANUFACTURING SUCH A DEVICE AND USES THEREOF
IL122840A (en) * 1997-12-31 2002-04-21 Radiancy Inc Apparatus and methods for removing hair
AU1934699A (en) * 1998-01-07 1999-07-26 Kim Robin Segal Diode laser irradiation and electrotherapy system for biological tissue stimulation
US7048731B2 (en) * 1998-01-23 2006-05-23 Laser Abrasive Technologies, Llc Methods and apparatus for light induced processing of biological tissues and of dental materials
US6173202B1 (en) * 1998-03-06 2001-01-09 Spectrx, Inc. Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue
US6530915B1 (en) * 1998-03-06 2003-03-11 Spectrx, Inc. Photothermal structure for biomedical applications, and method therefor
US6022316A (en) * 1998-03-06 2000-02-08 Spectrx, Inc. Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications
WO1999046005A1 (en) * 1998-03-12 1999-09-16 Palomar Medical Technologies, Inc. System for electromagnetic radiation of the skin
US6223071B1 (en) * 1998-05-01 2001-04-24 Dusa Pharmaceuticals Inc. Illuminator for photodynamic therapy and diagnosis which produces substantially uniform intensity visible light
DE19836649C2 (en) * 1998-08-13 2002-12-19 Zeiss Carl Meditec Ag Medical handpiece
US6936044B2 (en) * 1998-11-30 2005-08-30 Light Bioscience, Llc Method and apparatus for the stimulation of hair growth
US6663659B2 (en) * 2000-01-13 2003-12-16 Mcdaniel David H. Method and apparatus for the photomodulation of living cells
US6514242B1 (en) * 1998-12-03 2003-02-04 David Vasily Method and apparatus for laser removal of hair
US6183500B1 (en) * 1998-12-03 2001-02-06 Sli Lichtsysteme Gmbh Process and apparatus for the cosmetic treatment of acne vulgaris
US6183773B1 (en) * 1999-01-04 2001-02-06 The General Hospital Corporation Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
SE522249C2 (en) * 1999-01-13 2004-01-27 Biolight Patent Holding Ab Control device for controlling external processing by light
US6709269B1 (en) * 2000-04-14 2004-03-23 Gregory B. Altshuler Apparatus and method for the processing of solid materials, including hard tissues
US6685699B1 (en) * 1999-06-09 2004-02-03 Spectrx, Inc. Self-removing energy absorbing structure for thermal tissue ablation
US6210425B1 (en) * 1999-07-08 2001-04-03 Light Sciences Corporation Combined imaging and PDT delivery system
US6354370B1 (en) * 1999-12-16 2002-03-12 The United States Of America As Represented By The Secretary Of The Air Force Liquid spray phase-change cooling of laser devices
US6702808B1 (en) * 2000-09-28 2004-03-09 Syneron Medical Ltd. Device and method for treating skin
US20020149326A1 (en) * 2001-03-01 2002-10-17 Mikhail Inochkin Flashlamp drive circuit
DE10123926A1 (en) * 2001-03-08 2002-09-19 Optomed Optomedical Systems Gmbh irradiation device
US6679837B2 (en) * 2001-06-01 2004-01-20 Intlas Ltd. Laser light irradiation apparatus
US6723090B2 (en) * 2001-07-02 2004-04-20 Palomar Medical Technologies, Inc. Fiber laser device for medical/cosmetic procedures
US20030032900A1 (en) * 2001-08-08 2003-02-13 Engii (2001) Ltd. System and method for facial treatment
WO2003017670A1 (en) * 2001-08-15 2003-02-27 Reliant Technologies, Inc. Method and apparatus for thermal ablation of biological tissue
US20040082940A1 (en) * 2002-10-22 2004-04-29 Michael Black Dermatological apparatus and method
WO2003057059A1 (en) * 2001-12-27 2003-07-17 Palomar Medical Technologies, Inc. Method and apparatus for improved vascular related treatment
US6863781B2 (en) * 2002-02-26 2005-03-08 Massachusetts Institute Of Technology Process for photocatalysis and two-electron mixed-valence complexes
IL163946A0 (en) * 2002-03-12 2005-12-18 Gen Hospital Corp Method and apparatus for hair growth managment
DE60324125D1 (en) * 2002-04-09 2008-11-27 Altshuler Gregory DEVICE FOR PROCESSING HARD MATERIALS
BR0312430A (en) * 2002-06-19 2005-04-26 Palomar Medical Tech Inc Method and apparatus for treating skin and subcutaneous conditions
EP1653876A1 (en) * 2003-07-11 2006-05-10 Reliant Technologies, Inc. Method and apparatus for fractional photo therapy of skin
US8870856B2 (en) * 2003-08-25 2014-10-28 Cutera, Inc. Method for heating skin using light to provide tissue treatment

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2199453A1 (en) * 1972-05-12 1974-04-12 Busser Francis
AU1851583A (en) * 1982-08-27 1984-03-01 Alistair Joseph Blake Lamp for irradiating tumours
EP0724894A2 (en) * 1995-02-03 1996-08-07 ESC Medical Systems Ltd. Method and apparatus for therapeutic electromagnetic treatment
WO1999049937A1 (en) * 1998-03-27 1999-10-07 The General Hospital Corporation Method and apparatus for the selective targeting of lipid-rich tissues
US20010041886A1 (en) * 1999-12-10 2001-11-15 Durkin Anthony J. Method of treating disorders associated with sebaceous follicles

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1523283A1 *

Cited By (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8328794B2 (en) 1996-12-02 2012-12-11 Palomar Medical Technologies, Inc. System for electromagnetic radiation dermatology and head for use therewith
US8002768B1 (en) 1997-05-15 2011-08-23 Palomar Medical Technologies, Inc. Light energy delivery head
US7935107B2 (en) 1997-05-15 2011-05-03 Palomar Medical Technologies, Inc. Heads for dermatology treatment
US7763016B2 (en) 1997-05-15 2010-07-27 Palomar Medical Technologies, Inc. Light energy delivery head
US8328796B2 (en) 1997-05-15 2012-12-11 Palomar Medical Technologies, Inc. Light energy delivery head
US8182473B2 (en) 1999-01-08 2012-05-22 Palomar Medical Technologies Cooling system for a photocosmetic device
US7942916B2 (en) 2002-05-23 2011-05-17 Palomar Medical Technologies, Inc. Phototreatment device for use with coolants and topical substances
US7942915B2 (en) 2002-05-23 2011-05-17 Palomar Medical Technologies, Inc. Phototreatment device for use with coolants
US10556123B2 (en) 2002-06-19 2020-02-11 Palomar Medical Technologies, Llc Method and apparatus for treatment of cutaneous and subcutaneous conditions
US8915948B2 (en) 2002-06-19 2014-12-23 Palomar Medical Technologies, Llc Method and apparatus for photothermal treatment of tissue at depth
US10500413B2 (en) 2002-06-19 2019-12-10 Palomar Medical Technologies, Llc Method and apparatus for treatment of cutaneous and subcutaneous conditions
US8506979B2 (en) 2002-08-28 2013-08-13 Nomir Medical Technologies, Inc. Near-infrared electromagnetic modification of cellular steady-state membrane potentials
US7255560B2 (en) 2002-12-02 2007-08-14 Nomir Medical Technologies, Inc. Laser augmented periodontal scaling instruments
US7470124B2 (en) 2003-05-08 2008-12-30 Nomir Medical Technologies, Inc. Instrument for delivery of optical energy to the dental root canal system for hidden bacterial and live biofilm thermolysis
US9314302B2 (en) 2004-06-24 2016-04-19 Virulite Llc Cosmetic uses of electromagnetic radiation
WO2006076506A3 (en) * 2005-01-13 2006-10-19 Candela Corp Treating a diseased nail
WO2006076506A2 (en) * 2005-01-13 2006-07-20 Candela Corporation Treating a diseased nail
WO2006089227A3 (en) * 2005-02-18 2007-02-08 Palomar Medical Tech Inc Dermatological treatment device
JP2008529746A (en) * 2005-02-18 2008-08-07 パロマー・メディカル・テクノロジーズ・インコーポレイテッド Dermatological treatment device
WO2006089227A2 (en) * 2005-02-18 2006-08-24 Palomar Medical Technologies, Inc. Dermatological treatment device
US10434324B2 (en) 2005-04-22 2019-10-08 Cynosure, Llc Methods and systems for laser treatment using non-uniform output beam
US9108044B2 (en) 2005-06-14 2015-08-18 Virulite Distribution Limited Use of electromagnetic radiation in the treatment of sensory organs
US8346347B2 (en) 2005-09-15 2013-01-01 Palomar Medical Technologies, Inc. Skin optical characterization device
EP1983888A4 (en) * 2006-01-24 2010-03-17 Nomir Medical Technologies Inc Optical method and device for modulation of biochemical processes in adipose tissue
EP1983888A2 (en) * 2006-01-24 2008-10-29 Nomir Medical Technologies, Inc Optical method and device for modulation of biochemical processes in adipose tissue
US9028536B2 (en) 2006-08-02 2015-05-12 Cynosure, Inc. Picosecond laser apparatus and methods for its operation and use
US10966785B2 (en) 2006-08-02 2021-04-06 Cynosure, Llc Picosecond laser apparatus and methods for its operation and use
US11712299B2 (en) 2006-08-02 2023-08-01 Cynosure, LLC. Picosecond laser apparatus and methods for its operation and use
US10849687B2 (en) 2006-08-02 2020-12-01 Cynosure, Llc Picosecond laser apparatus and methods for its operation and use
US9079021B2 (en) 2008-07-14 2015-07-14 Virulite Distribution Limited Electromagnetic radiation and its therapeutic effect
WO2010007419A1 (en) * 2008-07-14 2010-01-21 Virulite Distribution Limited Electromagnetic radiation therapy
GB2470927A (en) * 2009-06-10 2010-12-15 Dezac Group Ltd Phototherapy apparatus with skin temperature control
US8814922B2 (en) 2009-07-22 2014-08-26 New Star Lasers, Inc. Method for treatment of fingernail and toenail microbial infections using infrared laser heating and low pressure
US9919168B2 (en) 2009-07-23 2018-03-20 Palomar Medical Technologies, Inc. Method for improvement of cellulite appearance
WO2013090058A3 (en) * 2011-12-12 2013-11-07 Candela Corporation Devices for the treatment of biological tissue
US8728064B2 (en) 2011-12-12 2014-05-20 Candela Corporation Devices for the treatment of biological tissue
US10305244B2 (en) 2012-04-18 2019-05-28 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US11664637B2 (en) 2012-04-18 2023-05-30 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US9780518B2 (en) 2012-04-18 2017-10-03 Cynosure, Inc. Picosecond laser apparatus and methods for treating target tissues with same
US10581217B2 (en) 2012-04-18 2020-03-03 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US11095087B2 (en) 2012-04-18 2021-08-17 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US8888830B2 (en) 2012-09-10 2014-11-18 Dermal Photonics Corporation Systems and methods for usage replenishment
US10695582B2 (en) 2012-09-10 2020-06-30 Dermal Photonics Corporation Systems and methods for treating dermatological imperfections
US8974443B2 (en) 2012-09-10 2015-03-10 Dermal Photonics Corporation Systems and methods for treating dermatological imperfections
US11446086B2 (en) 2013-03-15 2022-09-20 Cynosure, Llc Picosecond optical radiation systems and methods of use
US10245107B2 (en) 2013-03-15 2019-04-02 Cynosure, Inc. Picosecond optical radiation systems and methods of use
US10765478B2 (en) 2013-03-15 2020-09-08 Cynosurce, Llc Picosecond optical radiation systems and methods of use
US10285757B2 (en) 2013-03-15 2019-05-14 Cynosure, Llc Picosecond optical radiation systems and methods of use
USD747800S1 (en) 2013-09-10 2016-01-19 Dermal Photonics Corporation Dermatological medical device
EP3624722A4 (en) * 2017-05-18 2020-11-18 Lightfective Ltd. Methods and devices for treatment of subcutaneous fat
CN110621247A (en) * 2017-05-18 2019-12-27 光效有限公司 Method and apparatus for subcutaneous fat therapy
WO2018211492A1 (en) 2017-05-18 2018-11-22 Lightfective Ltd. Methods and devices for treatment of subcutaneous fat
US11418000B2 (en) 2018-02-26 2022-08-16 Cynosure, Llc Q-switched cavity dumped sub-nanosecond laser
US11791603B2 (en) 2018-02-26 2023-10-17 Cynosure, LLC. Q-switched cavity dumped sub-nanosecond laser

Also Published As

Publication number Publication date
US7351252B2 (en) 2008-04-01
EP1523283A1 (en) 2005-04-20
US20040093042A1 (en) 2004-05-13
IL197542A (en) 2015-05-31
JP2006500972A (en) 2006-01-12
BR0311901A (en) 2005-04-05
IL165418A (en) 2009-11-18
IL165418A0 (en) 2006-01-15
CA2487987C (en) 2010-04-13
CN100482182C (en) 2009-04-29
AU2003238302B2 (en) 2008-12-11
AU2003238302A1 (en) 2004-01-06
CA2487987A1 (en) 2003-12-31
HK1080341A1 (en) 2006-04-28
CN1665453A (en) 2005-09-07

Similar Documents

Publication Publication Date Title
US7351252B2 (en) Method and apparatus for photothermal treatment of tissue at depth
US8915948B2 (en) Method and apparatus for photothermal treatment of tissue at depth
US20230031914A1 (en) Device including rf source of energy and vacuum system
US20160220834A1 (en) Method and system for skin treatment
AU784423B2 (en) Method and apparatus for medical treatment utilizing long duration electromagnetic radiation
US20170106201A1 (en) Combination of magnetic and electromagnetic treatment method
US20070255355A1 (en) Apparatus and method for skin treatment with compression and decompression
US20040162596A1 (en) Methods and apparatus for performing photobiostimulation
US20100286673A1 (en) Method and apparatus for treatment of tissue
EP3413974A1 (en) Apparatus and cosmetic method for treating hyperhidrosis
KR20120090007A (en) Devices and methods for percutaneous energy delivery
KR20050024353A (en) Method and apparatus for treatment of cutaneous and subcutaneous conditions
Lee et al. Non-ablative Lasers
Garibyan et al. 12 Body contouring: Noninvasive fat reduction

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2487987

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003238302

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020047020627

Country of ref document: KR

Ref document number: 2004516013

Country of ref document: JP

Ref document number: 20038140454

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2003737199

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020047020627

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2003737199

Country of ref document: EP